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1.1 The Synaptic Vesicle Cycle 
The synapse is the communication site between two neurons. Neurotransmitters 
are the molecules passing on the signal and are stored in synaptic vesicles (SVs). An 
incoming action potential mediates calcium influx through calcium channels triggering 
fusion of SVs with the plasma membrane and releasing the neurotransmitters into the 
synaptic cleft, a process called exocytosis. The content of a single vesicle released is the 
elementary unit, or quantum, of synaptic transmission, first postulated by Katz [1]. 
Postsynaptic receptors are then activated by neurotransmitter binding allowing ion 
influx into the postsynaptic cell generating a new action potential.  
SV exocytosis is confined to specific membrane compartments of the presynapse 
referred to as active zones and proceeds in three temporally and spatially distinct steps: 
docking, priming and fusion. In the docking step SVs are recruited into the active zone 
and positioned in close proximity to the plasma membrane [2]. Priming is the process 
by which vesicles become fusion competent as they wait for a Ca2+ triggering signal, 
defined as the ready releasable pool (RRP) of vesicles [3]. Synaptotagmin is a 
regulatory factor, which primes SV into a fusion-ready state and fuses upon a Ca2+ 
influx [4].  
After exocytosis new SVs are endocytosed, recycled and refilled with 
neurotransmitter for another round of exocytosis. Sustained synaptic transmission is a 
highly synchronised interplay between repetitive exo- and endocytotic processes which 
are part of the synaptic vesicle cycle (fig. 1.1).  
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Figure 1.1 The synaptic vesicle cycle. Schematic delineation of key steps in presynaptic 
neurotransmitter release. After docking and priming SVs release their content upon fusion with 
the plasma membrane. After direct or early endosomal recycling, SVs are refilled with 
neurotransmitter and proceed to a next round of exocytosis. Scheme taken from [2]. 
 
1.2 Synaptic Vesicle 
SVs are the key organelles of synaptic transmission. To understand the essence 
of neurotransmission a detailed comprehension of the vesicle architecture is required. 
SVs exhibit a homogenous size distribution with a diameter of about 40 nm and can be 
highly enriched by purification procedures including size exclusion chromatography [5] 
[6]. This makes them accessible for biochemical and proteomic studies.  
In 2006, Takamori and co-workers succeeded on the quantification of an average 
SV including its protein and lipid composition by mass spectrometry analysis (fig. 1.2 ) 
[7]. The major phospholipid components of the membrane are phosphatidylcholine 
(PC), phosphatidylethanolamine (PE), phosphatidylserine (PS) and phosphatidylinositol 
(PI). In addition to phospholipids, cholesterol is highly predominant comprising about 
40% of all lipids. 
Many proteins were identified, including fusion relevant proteins and their 
interaction partners. Furthermore, SVs contain the vacuolar-type H+-ATPase (V-
ATPase) which energises neurotransmitter filling in the lumen. In the presence of 
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cytosolic ATP it generates an electrochemical gradient (ΔµH+) across the vesicle 
membrane that is required for the transport of neurotransmitters into the SV. With 1-2 
copies per vesicle it is low in abundance. 
Neurotransmitter translocation is mediated by vesicular neurotransmitter 
transporters. Their activity directly depends on the V-ATPase induced ΔµH+, as they are 
secondary active transporters. The average copy number for the vesicular glutamate 
transporter (VGLUT) 1 and 2 was determined to be ~9 and ~14, respectively.  
 
Figure 1.2 Molecular model of an average SV. The model is based on quantitative analysis of 
the protein and lipid contents. Protein structures were taken either from crystallographic studies 
(if available) or from computational modelling. The average height of the V-ATPase is ~20 nm 
and the membrane diameter is ~4 nm. The concentration of neurotransmitters in a SV is 
estimated to 100-150 mM which would correspond to ~1500 molecules. Taken from [7]. 
1.3 Synaptic Strength and Plasticity 
Synaptic strength and plasticity are parameters which modulate essential 
processes in the brain, such as learning, memory and coordinative functions. 
The changes in exocytotic release upon successive stimulation define synaptic 
plasticity. The extent of synaptic strength is, apart from changes in postsynaptic 
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receptor expression, dependent on the amount of neurotransmitter released upon 
stimulation. It is known that postsynaptic receptors in synapses are not always saturated 
upon a single exocytotic event, e.g. in the calyx of Held [8] and in hippocampal and 
cerebellar synapses [9] [10], directing the focus to SV quantal size as a crucial 
regulating factor of synaptic strength and plasticity. However, little is known about 
presynaptic regulation of quantal size.  
Vesicular neurotransmitter transporters fill SVs with neurotransmitter molecules 
and are therefore critical for quantal size [11]. It was found that the level of VGLUT 
expression does indeed seem to influence quantal size [12] [13]. Furthermore, reduction 
of vesicular acetylcholine transporter (VAchT) expression in the neuromuscular 
junction reduces SV filling and affects the release of acetylcholine [14]. On the other 
hand, data from Drosophila suggest that a single VGLUT is sufficient to fill a SV with 
glutamate [15]. However, not much is known about the mechanisms by which vesicular 
neurotransmitter transporters regulate SV filling as they are scarcely accessible to 
standard electrophysiological approaches due to their intracellular localisation. 
Understanding the mechanisms of SV filling will provide clarification of fundamental 
questions regarding synaptic function. 
1.4 Neurotransmitter Filling of SVs 
1.4.1 Electrochemical Gradient and Chloride Channels 
Neurotransmitter filling into SVs by neurotransmitter transporters is fueled by 
the V-ATPase generated ΔµH+ (section 1.3). V-ATPase is converting cytosolic ATP 
into ADP, Pi and H
+, which are then transported into the vesicle lumen. This gives rise 
to the ΔµH+ across the membrane, composed of the membrane potential (ΔΨ) and the 
pH gradient (ΔpH): 
 
ΔµH+ = ΔΨ + (2.3 RT/zF) log ([H+]in/[H
+]out) 
  
R = gas constant, T = temperature [K], z = ion valence, F = Faraday constant.  
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Since the V-ATPase is electrogenic, it requires charge balance for H+. Cl- 
functions as counter ion for H+ charge balance. Consequently, the established ΔµH+ 
critically depends on the external Cl- concentration. At lower Cl- concentrations, ΔΨ is 
the major component of ΔµH+ due to a lack of counter ions. With increasing Cl- 
concentration the SV can be acidified to a higher extent, with predominating ΔpH 
(fig.1.3).  
It is still under debate which molecule is mediating Cl- conductance on SVs [16]. Cl- 
channels (ClCs) 3 and 7 are the prime candidates proposed to be involved in the 
bioenergetics of vesicular neurotransmitter filling [17]. It should be noted that related 
ClCs have been shown to function as Cl-/H+ exchangers rather than Cl- channels [18] 
[19]. Apart from ClCs, vesicular neurotransmitter transporters are discussed as putative 
Cl- shunts [20] [21]. 
 
Figure 1.3 The electrochemical gradient formation across a semipermeable membrane. 
Interplay of ΔµH+ components ΔΨ and ΔpH as a function of the external chloride 
concentration.Picture taken from [22] and kindly provided by Reinhard Jahn. 
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1.4.2 Vesicular Neurotransmitter Transporters 
Traditionally, neurons are classified depending on the neurotransmitter they 
release. The neurotransmitter transporters, which fill SVs with neurotransmitters by 
using ΔµH+ as an energy source, can be subdivided in three classes: VMATs/VAchT, 
VIAAT (or VGAT) and VGLUTs.  
Monoamines such as dopamine, serotonine, noradrenaline and adrenaline are 
substrates of vesicular monoamine transporters (VMATs). There are two isoforms of 
VMATs with VMAT2 mainly expressed in the brain [23] [24] and VMAT1 in the 
periphery such as chromaffin cells of the adrenal gland [25] [26]. VMATs display high 
affinity towards their substrate in the submicromolar range [27] [24], which is necessary 
given the low cytosolic concentrations and toxicity of monoamines. The transport 
mechanism of VMATs has been extensively characterised. Two luminal protons are 
exchanged for one positively charged monoamine, therefore neurotransmitter transport 
mainly depends on the ΔpH component of ΔµH+ [28].  
VAchT is closely related to the VMATs but is responsible for acetylcholine 
transport [29] [30]. In contrast to VMATs it exhibits a Km of ~1 mM [31] suggestive of 
a higher cytosolic concentration of acetylcholine. Similarly to VMATs, it transports one 
acetylcholine for two protons [32].  
The vesicular inhibitory amino acid transporter (VIAAT or VGAT), identified 
by two independent studies in 1997 [33] [34], exhibits low substrate affinity to γ-
aminobutyric acid (GABA) in the 5 mM range and a Km of 25 mM for glycine. 
Transport is driven simultaneously by ΔpH and ΔΨ. The proposed transport mechanism 
includes H+/GABA antiport. Juge and coworkers obtained biochemical evidence of a 
chloride conductance by VIAAT, by using an in vitro system [20] By contrast, 
Riazanski and colleagues performed electrophysiological and biochemical studies 
demonstrating an absolute requirement of the chloride channel ClC3 for vesicular 
GABA filling [35] [36]. How exactly GABA and glycine are accumulated in SVs 
remains contentious.  
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VGLUTs will be discussed in separate section, as they are the main focus of the 
present work. An overview of vesicular neurotransmitter transporters including ionic 
coupling and ΔµH+ contribution is depicted in figure 1.5. 
1.5 Vesicular Glutamate Transporters 
Three different vesicular glutamate transporters (VGLUTs) have been identified. 
VGLUT1 [37] [38], VGLUT2 [39-41] [42] and VGLUT3 [43] [44] [45] [46]. VGLUT1 
and 2 were initially described as brain-specific or differentiation-associated Na+-
dependent inorganic phosphate transporters. These include BNPI [47] and DNPI [48], 
both located on the plasma membrane of synapses and work by transporting inorganic 
phosphate into the cytosol. Later on, they were discovered to translocate L-glutamate, 
the major excitatory neurotransmitter, into SVs with high specificity [37] [38]. 
VGLUT has a low substrate affinity of 2-4 mM. Unlike dopamine, the cytosolic 
concentration of glutamate is considerably high (10 mM), thus high substrate affinity is 
not necessarily required. By contrast, plasma membrane glutamate transporters display a 
much higher affinity [49] as they have to rapidly clear the synaptic cleft from glutamate 
to reduce receptor activation time. 
1.5.1 VGLUT Expression  
VGLUTs exhibit mutually exclusive distribution patterns in the brain with very 
limited overlap. VGLUT1 is mainly expressed in the cerebral cortex and hippocampus 
and VGLUT2 in the thalamus and brain stem [22]. VGLUT1/2 expressing synapses 
define the glutamatergic phenotype of neurons. VGLUT1/2 expression in the brain is 
not only restricted to neurons, but is further detected in synaptic-like microvesicles 
(SLMVs) in astrocytes [50] which are capable of releasing glutamate [51].  
Unlike the predominant two isoforms, VGLUT3 is expressed in neurons 
exhibiting cholinergic, serotonergic and gabaergic phenotypes [46] [45]. In cochlear 
inner hair cell synapses and in pain-sensing neurons of the dorsal root ganglion, 
VGLUT3 is the essential neurotransmitter transporter [52] [53]. 
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1.5.2 Glutamate Co-Release and Vesicular Synergy 
Expression of VGLUT3 in non-glutamatergic neurons was surprising, as until 
then it was believed that neurons release only one type of transmitter (Dale’s principle) 
and that VGLUTs are expressed in glutamatergic neurons only. Meanwhile, studies 
suggest that neurons are capable of releasing two neurotransmitters from the same 
release site, reviewed in [22] [54]. Dopaminergic neurons expressing VGLUT2 have 
been shown to co-release glutamate [55] [56] and gabaergic neuron cultures transfected 
with VGLUT3 were capable of releasing GABA and glutamate [57].  
A synergistic effect by VGLUTs on monoamine, GABA and acetylcholine 
filling by alteration of ΔµH+ has also been proposed. VGLUTs can promote ΔpH 
formation by translocating glutamate as a counter ion for H+. VGLUT3 knock out (ko) 
reduces acetylcholine release in striatum slices [58], whereas dopamine storage is 
enhanced by VGLUT2 in cultured midbrain neurons [56]. However, the consequences 
of co-release for vesicle filling, neurotransmission and synaptic plasticity are just 
starting to be understood. 
1.5.3 VGLUT Knock Out 
VGLUT1 ko mice did not display any distinctive features up to 2 weeks after 
birth. Thereafter, ko mice showed severe impairment in coordination, learning and 
memory, largely surviving several months after birth [59] [13]. Miniature excitatory 
postsynaptic current (mEPSC) amplitudes in VGLUT1 ko neurons were significantly 
smaller compared to wild type (wt) neuron amplitudes, implicating reduced glutamate 
filling into SVs [13]. VGLUT2 ko causes perinatal lethality [60] [61]. In heterozygous 
thalamic neurons, a reduction in postsynaptic response further affirmed VGLUTs being 
critically important for quantal size [60].  
The inner hair cell are the sensory receptors of the auditory nerve pathway. As 
their synapses are glutamatergic, VGLUT3 ko mice are completely deaf [52]. 
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1.5.4 VGLUT Structure and Interaction Partners 
Structurally, VGLUTs share 76% amino acid identity in humans, with highly 
homologous transmembranal domains and N-and C-terminal tails displaying very little 
homology. Hydropathy analysis predicts 12 transmembranal domains connected by 
loops. The N- and C-terminal tails are facing the cytoplasmic side of the vesicular 
membrane (fig.1.4). 
Mutation studies found the residues His128, Arg184 and Glu191, which are highly 
conserved among VGLUTs to play a decive role glutamate translocation. Remarkably, 
these mutations did not seem to alter Na+/Pi transport, indicating two distinct transport 
machineries for L-glutamate and Na+/Pi [62]. 
A modelling study based on a remote bacterial homolog of VGLUTs showed 
that Arg80, Arg314, Arg176 and His120 as key residues for glutamate binding. The residue 
directly involved in Pi binding was found to be Arg
314 (fig.1.4) [63], which further 
affirms the presence of two independent transport mechanisms in VGLUTs for L-
glutamate and Na+/Pi. Moreover, in the original study on the identification of VGLUT1 
Pi did not inhibit L-glutamate uptake in SVs [38], consistent with the view on two 
binding sites. 
VGLUT1 has one putative N-glycosylation site predicted by computational tools 
(NetNGlyc 1.0). Beyond that, there is no clear experimental evidence for glycosylation. 
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Figure 1.4 Predicted model of VGLUT1 structure. A. Transmembranal domain prediction 
based on topology of bacterial MFS proteins. According to this, VGLUT1 would exhibit 12 
putative transmembrane segments. B. Cytoplasmic view on the packing of helices. Marked 
residues are supposed to be involved in glutamate binding. C. Cartoon representation of human 
VGLUT1 structure. The transmembrane helices are predicted to form a pore which is open 
towards the cytoplasmic side. Taken from [63]. 
 
Despite their spatially and temporally distinct expression patterns, which suggest 
specific roles for each isoform, not much is known about their functional differences. 
Transport rates, substrate affinity and pharmacological responses are similar, implying 
the same glutamate transport mechanism. However, neurons that express VGLUT1 or 2 
show varying probabilities in glutamate release [40] [64]. Recently, Weston and co-
workers demonstrated that differences in glutamate release probability are in fact 
attributed to the VGLUT isoform expressed in that specific neuron. In particular, 
alterations in release probability were induced by the interaction of VGLUT1 with 
endophilinA1 [57], which had been previously described [65] [66] [67].  
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1.5.5 Transport Mechanisms and Regulation of VGLUT1 
Glutamate transport by VGLUTs mainly depends on ΔΨ [68]. An intriguing 
feature of VGLUT is its biphasic dependence on Cl- with maximal activity between 4-6 
mM [69] and inhibition of glutamate uptake with increasing Cl- concentrations (fig.1.3) 
[69] [70].  
1.5.5.1 Allosteric Regulation of VGLUT1 and the Contribution of ΔpH to 
Glutamate Filling 
The stimulatory effect on glutamate uptake at low Cl- concentrations has been 
proposed to be related to allosteric regulation of VGLUT by Cl- [68] [71] [70] whereas 
some studies suggest the stimulating effect originates from an increase in ΔpH evoked 
by Cl- influx [69] [72]. Inhibition of glutamate uptake at high Cl- concentrations is 
believed to be related to the dissipation of ΔΨ and predominance of ΔpH [70]. 
Dissipation of ΔpH at 4 mM Cl- and low glutamate concentrations (50 µM) enhanced 
steady state glutamate filling in SVs showing that glutamate uptake can solely be driven 
by ΔΨ [73] [70]. However, at physiological glutamate concentrations (4 mM) a 
decrease in glutamate uptake was observed in the presence of 20 mM Cl- when ΔpH 
was abolished. The decrease originated from a net efflux of glutamate in the presence of 
high Cl-. Thus, ΔpH was found to be important for retaining glutamate in the SV lumen 
[70]. Glutamate uptake dependence on ΔpH is suggestive of a glutamate/H+ antiport 
mechanism underlying VGLUT1. Exchange of a luminal H+ for one glutamate results in 
neutralisation of two positive luminal charges, which is explaining the strong 
dependence of VGLUT on ΔΨ.  
1.5.5.2 Cl- Conductance by VGLUT1  
A first indication for Cl- transport by VGLUT was found when VGLUT1 was 
heterologously overexpressed in PC12 cells resulting in an increase of the Cl- 
conductance [38]. Recent work using a reconstituted in vitro system containing a 
bacterial proton pump and VGLUT1, observed chloride conductance mediated by 
VGLUT1 [21]. Cl- and glutamate were competing with each other for entering the 
liposome lumen. On the other hand, Evans Blue, a VGLUT inhibitor, did not abolish Cl- 
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transport by VGLUT1, indicating two independent transport machineries for glutamate 
and Cl-. By contrast, in a later study Cl- transport by VGLUT2 reconstituted in 
liposomes was not observed [74]. Furthermore, a study on small synaptic-like 
microvesicles (SLMVs) from astrocytes expressing VGLUT2 did not exhibit Cl- 
dependent acidification, a unique phenomenon which has never been observed in SVs 
(unpublished work). This finding suggests that Cl- conductance in SVs is mediated by a 
molecule other than VGLUT. Regarding the conflicting reports on Cl- transport by 
VGLUT1, it remains to be resolved whether Cl- conductance on SVs is mediated by 
VGLUT or by other molecules such as ClCs. 
1.5.5.3 Counter Transport of Glutamate and Cl- 
SVs are filled with ~ 130 mM NaCl during endocytosis. An exchange of a 
luminal Cl- for glutamate is thus physiologically and bioenergetically plausible, as it 
would prevent osmotic swelling of SVs. Several studies suggested an exchange 
mechanism of luminal Cl- with cytosolic glutamate [75] [70]. However, luminal SV 
contents are difficult to manipulate which is why an enhancing effect on glutamate 
uptake in presence of high luminal Cl- was not shown until the recent work by Schenck 
and co-workers. Using proteoliposomes containing VGLUT1 and a bacterial proton 
pump they observed dramatically enhanced glutamate uptake in presence of high 
luminal chloride [21]. In this system Cl- exchange could solely be mediated by 
VGLUT1 supporting a Cl-/glutamate exchange mechanism.  
1.5.5.4 Na+/Pi Co-transport by VGLUT 
Despite the fact that VGLUTs were initially identified as Na+/Pi transporters by 
detecting uptake in Xenopus laevis oocytes transfected with VGLUT mRNA [47], little 
is known about the Na+/Pi transport properties by VGLUTs. More recently, a Na
+-
dependent Pi uptake in liposomes reconstituted with a bacterial proton pump and 
VGLUT2 was reported [62], implicating that Na+/Pi transport is indeed an intrinsic 
property of VGLUTs. However, the effect of the Na+/Pi transport mechanism on 
glutamate uptake is still unclear (see also section 1.7.4). 
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1.5.5.5 Enhancement of Glutamate Uptake Underlying a H+/K+ Exchange 
Mechanism in SVs 
A novel glutamate uptake transport mode involving a K+/H+ exchange 
mechanism has also recently been described [76]. Exchange of cytosolic K+ with 
luminal H+ decreases ΔpH allowing more H+ to enter the vesicle lumen, thus increasing 
ΔΨ and promoting glutamate uptake. Yet, the protein mediating K+/H+ exchange has 
not been identified. Putative VGLUT transport modes are depicted in figure 1.5. 
Figure 1.5 Transport modes of vesicular neurotransmitter transporters. Schematic 
representation of current models on neurotransmitter ionic coupling in VMATs/VAchT, VIAAT 
and VGLUTs and its dependencies on ΔµH+. Taken from [75] [11] [77] [22] [54]. 
 
1.6 Motivation and Aim of the Study 
Vesicular neurotransmitter transporters play a key role in quantal size 
modification, as they fill SVs with transmitter. VGLUTs are expressed in about 80% of 
all central nervous system (CNS) neurons. Various questions addressing VGLUT 
regulation remain unanswered, such as the stoichiometry of ionic coupling, in which Cl- 
is proposed to be involved. Studies with contradicting findings regarding Cl- 
conductance by VGLUT1 have been reported [21] [74]. Furthermore, a K+/H+ exchange 
mechanism affecting the bioenergetics of glutamate transport has been described [76]. 
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This work in particular aimed to clarify the role of chloride in VGLUT function and the 
identification of a putative K+/H+ exchanger in order to elucidate the ionic mechanism 
of glutamate filling. 
Due to their organellar localisation transporters are scarcely accessible to 
physiological studies. Successful isolation of SVs from torpedo marmorata electromotor 
synapses and rat brain [5] [6] permitted to conduct pioneering work on SV transporters 
[78] [69] [79]. However, studies involving the manipulation of SV luminal content and 
the investigation of intrinsic transporter properties are limited.  
In this work, an in vitro setup composed of liposomes reconstituted with mouse 
VGLUT1 and an ATP synthase from Bacillus thermophilus used as proton pump to 
generate an energizing ΔµH+ was used as model system (fig.1.6). This minimal artificial 
system simplifies the study of intrinsic VGLUT transport modes and permits the 
investigation of effects on glutamate uptake based on the luminal ionic composition.  
The second focus of this work was the identification of a putative K+/H+ 
exchanger promoting glutamate uptake by SVs. For this study native SVs isolated from 
rat brain were used. 
 
Figure 1.6 Model system to study VGLUT function. A Bacillus thermophilus ATP synthase is 
reconstituted with mus musculus VGLUT1 in artificial membranes.  
 
Material and Methods 
 
2 Material and Methods 
2.1 Material 
Standard chemicals were purchased at analytical grade. Specific chemicals and 
buffers are individually mentioned in the method descriptions. 
2.1.1 Buffers and Media 
Buffer/media Composition 
Homogenisation buffer 320 mM sucrose, 5 mM HEPES, pH 7.4 
Glycine buffer 300mM glycine, 5 mM HEPES, pH 7.4 
Transfer buffer 200 mM glycine, 25 mM Tris, 0.04 % 
SDS, 20 % Methanol 
TBST 15 mM Tris-HCl, pH 7.4, 150 mM NaCl, 
0.5 % (v/v) Tween 20 
SDS running buffer (anode) 200 mM Tris-HCl, pH 8.9 
SDS running buffer (cathode) 100 mM Tris, 100 mM Tricin, 0.1 % SDS, 
pH 8.2 
Terrific Broth (TB) 12 g tryptone, 24 g yeast extract, 4 ml 
glycerol, 2.31 g KH2PO4, 12.54 g K2HPO4 
per 1 l 
Luria-Bertani medium (LB) 10 g tryptone, 5 g yeast extract and 10 g 
NaCl per 1 l 
YPTG media 3g KH2PO4, 9.13 g K2HPO4, 10 g yeast 
extract, 16 g bactotryptone, 5 g NaCl, 19.8 
g glucose per 1 l 
ExpressFive, Sf900 media Unknown composition, purchased from 
Invitrogen 
Cell culture medium DMEM, 10 % FCS, 4 mM glutamine, 100 
U/ml penicillin and streptomycin 
Table 2.1 Buffers and media and their compositions. 
 
2.1.2 Mammalian and Insect Cell Lines and Bacterial Strains 
Spodoptera frugiperda (Sf9) insect cell line was used for virus amplification and 
Trichoplusia ni (High5) insect cell line for VGLUT1 expression. The Human 
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Embryonic Kidney 293 cell line (HEK293) was used for large scale overexpression of 
VGLUT1. E.coli DH5α strain was used for molecular cloning and E.coli BL21 (DE3) 
was used for T7 RNA Polymerase overexpression. A19 bacterial strain was used for 
isolation of E.coli S30 extract. 
2.1.3 DNA Constructs 
Construct Vector Source 
Streptavidin binding peptide 
(SBP) tagged VGLUT1 (mus 
musculus) 
pDEST8 VGLUT1 cDNA (GeneArt), 
vector (Invitrogen) 
His6-tagged VGLUT1 (mus 
musculus) 
pDEST10 VGLUT1 cDNA 
(GeneArt),v ector 
(Invitrogen) 
His6 –tagged TF0F1 pTR19ASDS Masasuke Yoshida (Tokyo 
Institute of Technology 
/Japan) 
SBP-tagged VGLUT1 (mus 
musculus) 




pET29a(+) cloned by Maria Druminski 
T7 RNA Polymerase 
(T7RNAP) 
pAR1219 Frank Bernhard (University 
of Frankfurt) 
Table 2.2 Plasmids used for protein expression.  
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2.2 Methods 
2.2.1 LP2 and CPG-SV Isolation 
from Rat Brain 
Crude SVs (LP2) and CPG SVs 
(additionally purified by size exclusion 
chromatography) were purified as described in 
[7] based on the protocol by [6] using the 
homogenisation buffer. Glycine buffer was 
used for the size exclusion chromatography 
step. A scheme of the protocol is depicted in 
figure 2.7. LP2 and CPG-SVs were adjusted to 
a protein concentration of ~15 µg/µl and ~6 
µg/µl, snap frozen and stored at -80 °C.  
2.2.2 Protein Expression and 
Purification 
2.2.2.1 Purification of Bacillus 
thermophilus ATP-Synthase 
(TF0F1) 
The purification protocol for TF0F1 is 
based on [21]. The bacterial strain DK8 
carrying the plasmid pTR19ASDS [80] 
contains a His6-tagged β-subunit allowing 
affinity purification. Bacteria were grown in 2 l TBAmp (terrific broth) to an OD600 = 1.3 
- 1.7 and harvested by centrifugation. The pellets were resuspended in 50 mM Tris-HCl 
(pH 8.0), 0.5 mM EDTA, 1 x protease inhibitor complete (PIs) (Roche) and 1 mg/ml 
lysozyme and incubated for 1 hour at 37 °C. After addition of 5 mM MgCl2 (final 
conc.), the cells were sonicated on ice 4 x 30 sec with 30 sec break in between with a 50 
% output. The suspension was stirred for 20 min at room temperature (rt) after 
 
Figure 2.7 SV purification from rat 
brain. Flow scheme of the isolation of 
crude SVs (LP2) and pure SVs via size 
exclusion chromatography. Taken from 
[7]. 
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supplementation with 1 µg/ml DNaseI, 250 mM Na2SO4 and 0.7 % (w/v) NaCholate, 
and centrifuged at 20000 x g for 30 min at 4 °C. The resulting pellet was resuspended in 
20 mM HEPES, 100 mM KCl, 20 mM Imidazole, 5 mM MgCl2 (HEPES buffer) and 1 
% n-dodecyl-β-D-maltopyranoside (DDM), pH 7.6, stirred for 45 min at rt and 
centrifuged at 20000 x g for 30 min at 4 °C. The supernatant was batch incubated with 
Talon beads (Clontech) for 2 hours at 4 °C to bind the His-tagged TF0F1 complex. The 
beads were washed with 20 column volumes (CVs) of HEPES buffer containing 0.08 % 
DDM. Elution of the protein was performed in 5 x 1 CV, using 20 mM HEPES, 250 
mM Imidazole, 5 mM MgCl2 and 0.05 % DDM. Although the purified protein was 
already of high purity, an additional anion exchange step was performed in order to 
concentrate the sample and loose minor contaminants. Prior to binding the solubilised 
protein onto the MonoQ HR 5/5 column (GE), the sample was dialysed into 20 mM 
NaCl, 20 mM HEPES and 5 mM MgCl2, pH 7.5 (buffer A) over night at 4 °C. For the 
anion exchange purification an ÄKTA-system (ÄKTA purifier, GE) was used at rt with 
an elution step gradient (4 CV 0-18 % buffer B, 3 CV 18-60 % buffer B, 11 CV 60-100 
% buffer B) and a flow rate of 1 ml/min. Buffer B corresponds to buffer A 
supplemented with 1 M NaCl. The fraction size between 18 and 65 % buffer B was 300 
µl. The peak fractions were pooled, aliquoted and snap frozen with 10 % glycerol.  
2.2.2.2 Cell-Free Expression of Rat VGLUT1  
For the cell-free expression setup, most of the required components were 
purchased except for the T7 RNA Polymerase (T7RNAP) and E.coli S30 extract. 
Isolation protocols are described in the following sections.  
2.2.2.2.1 Purification of T7RNAP 
An over night culture of the bacterial strain BL21 containing the T7RNAP 
carrying plasmid pAR1219 [81] was added to 4 l of LBAmp media and grown at 37 °C 
under vigorous shaking until an OD600 of 0.6 - 0.8 was obtained. T7RNAP expression 
was induced by adding Isopropyl-β-D-thiogalactopyranosid (IPTG) to a final 
concentration of 1 mM. For expression, the cultures were incubated at 37 °C for another 
5 h and harvested by centrifugation. The resulting cell pellet was resuspended in 120 ml 
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of buffer A (30 mM Tris, pH 8.0, 10 mM EDTA, 50 mM NaCl, 5 % glycerol and 10 
mM of β-mercaptoethanol). The cells were disrupted with a french press device at 
20,000 psi and centrifuged at 20,000 x g for 30 min at 4 °C to remove the cell debris. 
DNA was precipitated by dropwise addition of a 10 % streptomycin sulfate solution to a 
final concentration of 2 %. The precipitated DNA was pelleted by centrifugation at 
30,000 x g for 30 min at 4 °C. The cleared supernatant was additionally filtered through 
a 0.45 µm filter and further purified by anion exchange chromatography using a MonoQ 
HR 10/10 column on an ÄKTA purifier system (GE). For this, the T7RNAP containing 
sample was applied to the column with a flow rate of 1 ml/min followed by elution with 
a continuous gradient from buffer A to buffer B in 15 CVs (buffer B = buffer A with 
500 mM NaCl). The elution fractions were analysed by SDS-PAGE and coomassie 
staining. Fractions containing T7RNAP were pooled, dialysed in buffer C (10 mM Tris, 
pH 8.0, 1 mM EDTA, 10 mM NaCl and 1 mM DTT), snap frozen with 50 % glycerol 
and stored at -80 °C [82]. 
2.2.2.2.2 Isolation of E.coli S30 Extract 
S30 extract was isolated from A19 bacterial strain. 5 l of YTPG medium were 
supplemented with A19 over night culture and grown under vigorous shaking at 37 °C. 
The cells were harvested during logarithmic growth phase at OD600 2.5-3.0, cooled 
down rapidly to avoid further growing and pelleted at 5000 x g for 15 min. The cell 
pellet was resuspended in 150 ml of ice cold S30 A buffer (10 mM Tris, pH 8.2, 14 mM 
MgAc2, 0.6 mM KCl and 6 mM β-mercaptoethanol) and repelleted at 8,000 x g for 10 
min and 4 °C. Resuspension and pelleting was repeated twice with a final centrifugation 
step of 30 min. 25 g of wet weight cell pellet were resuspended in 28 ml of S30 B buffer 
(10 mM Tris, 14 mM MgAc2, 0.6 mM KCl, 1 mM DTT, 0.1 mM PMSF, pH 8.2), 
disrupted at 20,000 Psi using a french press and centrifuged at 30,000 x g for 30 min 
and 4 °C. The upper, non-turbid part of the supernatant was removed and spun down 
using the same settings. Again, the upper clear part of the supernatant was removed, 
supplemented with NaCl to a final concentration of 400 mM and incubated at 42 °C for 
45 min. The supernatant, which turned turbid, was dialysed in two steps over night in 
S30 C buffer (10 mM Tris, pH 8.2, 14 mM MgAc2, 0.6 mM  KAc and 0.5 mM DTT) at 
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4 °C and centrifuged on the next day at 30,000 x g for 30 min. The upper, non-turbid 
part of the supernatant was aliquoted, snap frozen and stored at -80 °C [82].  
2.2.2.2.3 Cell-Free Reaction Setup for Rat VGLUT1 Expression  
The reaction setup contained a reaction mixture (RM) and a feeding mixture 
(FM), which supplemented the RM with components. RM (70 µl) and FM (980 µl) were 
separated by a dialysis membrane with a molecular weight cut-off (MWCO) of 12-14 
kDa. The components of RM and FM and their concentrations are listed in detail in 
[82]. His10-tagged rat VGLUT1 in pET28a(+) vector was used as a plasmid. The 
expression was optimised by varying incubation temperatures (27 and 30 °C) and time. 
2.2.2.3 Heterologous Expression and Purification of VGLUT1 in Insect Cells 
2.2.2.3.1 Expression of VGLUT1 in Insect Cells 
His6- and SBP-tagged mouse VGLUT1 (in pDEST10 and pDEST8 vector, 
respectively (section 1.2.9.3)) and inserted in the bacmid EMBacY (baculovirus coding 
DNA with an integrated yellow fluorescent protein (YFP) expression marker) via Tn7 
transposition in DH10 bacterial strain [83]. 30 min prior to VGLUT1-bacmid 
transfection, 106 Spodoptera frugiperda (Sf9) cells in 3 ml of media were seeded in a 3 
cm dish and kept at 27 °C. 20 µg of VGLUT1-bacmid per 3 cm dish were transfected 
using FuGENE HD Transfection Reagent (Promega) and incubated for 72 h at 27 °C to 
acquire the first viral generation V0. The budded virus containing supernatant was used 
to infect 25 ml (106 cells/ml) Sf9 suspension culture in order to obtain a higher viral 
titer. After 72 h of incubation at 27 °C the virus containing supernatant (V1) was 
harvested and used to infect 400 ml Trichoplusia ni (High5) suspension culture (0.7 * 
106 cells/ml) for protein expression. VGLUT1 expression was monitored by 
measurement of YFP fluorescence and was highest 36 h post-infection (PI) with 10 mg/l 
expressed protein. High5 cells were harvested 36-48 h PI and processed for VGLUT1 
isolation. Sf9 cells were cultured in Sf900 and High5 cells in ExpressFive medium 
supplemented with 2 mM L-glutamine (Invitrogen). 
2.2.2.3.2 Detergent Screen for Solubilisation of VGLUT1 from Insect Cells 
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For the detergent screen the commercially available membrane protein kit 
(Qiagen) was used. Screen was performed according to the manufacturer’s protocol.  
2.2.2.3.3 Purification of SBP-tagged VGLUT1 from Insect Cells 
High5 cells from 1 l culture were suspended in 50 ml ice cold buffer A (40 mM 
Tris, pH 7.3, 300 mM KCl, 2 mM EDTA) with 1 x PIs and 5 mM β-mercaptoethanol. 
DDM was added to a final concentration of 2 % (w/v) and cells were lysed for 1 h at 4 
°C under constant rotation. Subsequently, insoluble cell debris were separated at 
300,000 x g for 30 min at 4 °C. The supernatant was supplemented with 1 ml 
streptavidin beads (Pierce) which were capturing VGLUT1 via its SBP-tag [84] and 
rotated for 3 h at 4 °C. The beads were washed with 2 x 10 CVs of wash buffer (buffer 
A containing 0.1 % DDM) and the protein was finally eluted with 5 x 1 CV of elution 
buffer (15 mM Tris, 100 mM KCl, 0.6 mM EDTA, 2 mM (+) biotin, 5 mM β-
mercaptoethanol and 0.05 % DDM). The beads were incubated for 5 min on ice for each 
elution step. The elution fractions were pooled and concentrated using a 30 kDa 
MWCO VivaSpin concentrator (Sartorius) to a final VGLUT1 concentration of ~1 
mg/ml (~ 3-5 fold). DDM has a micellar size of 50 kDa, thus accumulates in the 
concentrated protein sample to a final concentration of ~0.25 %. Concentrated 
VGLUT1 was aliquoted, snap frozen and stored at -80 °C. An average yield from 1 l of 
High5 cell culture was 1 mg.  
2.2.2.4 Heterologous Expression and Purification of VGLUT1 in HEK293 
cells 
HEK293 cells were cultured in DMEM (Dulbeccos’s modified Eagle’s medium, 
Lonza) supplemented with 10 % fetal bovine serum (FBS), 2 mM L-glutamine and 
1mM sodium pyruvate, incubated at 37 °C and 5 % CO2. For large-scale expression of 
VGLUT1, typically 100 dishes (10 cm diameter containing 10 ml of media) with ~60 % 
confluence were transfected with 20 µg DNA per plate using the Ca3(PO4)2 transfection 
method [85]. Mouse SBP-VGLUT1/pcDNA6.2 (section 1.2.9.3) was used as plasmid. 
24h prior to transfection, cells were split to ~30 % confluence and incubated at 37 °C 
and 2.5 % CO2. 1h before transfection, the cells were supplemented with fresh media. 
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For transfection of one dish, 20 µg of DNA (1 µg/µl) were mixed with 500 µl 250 mM 
CaCl2 (diluted from a 2.5 M stock), subsequently, 2 x BBS (BES-buffered saline: 50 
mM BES, 280 mM NaCl, 1.5 mM Na2HPO4) was added dropwise to the DNA/CaCl2 
mixture under constant agitation. DNA-Ca3(PO4)2 precipitant formation was observed 
by the turbid appearance of the solution. 5min later, the transfection mixture was 
carefully added to the cells and incubated for 24h at 37 °C and 2.8 % CO2. On the 
following day, CO2 was increased to 5 % and incubated for another 24h before 
harvesting and processing the cells.  
The purification of VGLUT1 was performed according to 2.2.2.3.2. The final 
concentration of DDM in the VGLUT1 sample was ~1 % (~20 fold concentration). 
Typically, 60-100 µg of VGLUT1 were obtained from 100 dishes and 3 l of used media 
in total.  
2.2.3 Reconstitution of VGLUT1 and TF0F1 into Liposomes 
2.2.3.1 VGLUT/TF0F1 Liposomes from Soybean Lipids formed by the Co-
Micellisation Method 
Proteoliposomes produced by the co-micellisation method were formed by 
detergent removal after mixing of the detergent-solubilised components by dialysis [86]. 
The components were soybean phospholipids (40 mg/ml in 5 % n-Octyl-β-D-
Glucopyranoside (OG)) (Sigma), cholesterol (5 mg/ml, 7 % OG) and proteins 
(VGLUT1, TF0F1, both in DDM). The molar ratio of phospholipids:cholesterol was 
adjusted to 75:25 with an estimated MW of 800 g/mol for the phospholipids. The ratio 
of lipids:TF0F1 was set  to 50 and for VGLUT1 to 25. The final lipid concentration was 
adjusted to 2.5 mg/ml. After mixing, the solution was dialysed (12-14 kDa MWCO, 
SpectraPor) over night at 4 °C in 10 mM MOPS, pH 7.3, 2 mM MgSO4 and 100 mM 
KGluconate, CholineGluconate, CholineCl or KCl, respectively. The dialysis buffer was 
additionally supplemented with 2 g BioBeads (BioRad) to adsorb detergent monomers. 
After dialysis, remaining DDM in the liposomes was complexed with 2,6-di-O-methyl-
β-cyclodextrin (β-CD, Sigma) [87] by adding a few crumbs of solid β-CD to the liposomes 
and incubated on ice for 1 h by occasionally inverting the tubes.  
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External buffer exchange was performed using prepacked size exclusion columns 
(PD10, GE). Up to 1 ml of liposomes was applied on one column. The liposome fractions 
were identified by their viscous and turbid appearance and collected separately.  
2.2.3.2 VGLUT1/TF0F1 Liposomes from Synthetic Lipids formed by the Step-
by-Step Method  
The step-by-step method for formation of proteoliposomes consists of 3 steps, 
which are 1) Preparation of unilamellar preformed liposomes, 2) Addition of proteins 
and detergent, 3) Removal of detergent [86].  
Unilamellar liposomes with synthetic lipids 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) and 
cholesterol (Chol) (Avanti Polar Lipids) with varying molar ratios were prepared by 
reverse phase evaporation [88]. In brief, the organic solvent from lipids dissolved in 
chloroform:methanol 2:1 was evaporated forming a lipid film. The lipid film was 
solubilised by diethylether followed by addition of an equal volume of buffer, which 
resulted in a two-phase system that is sonicated to form inverted water in oil micelles. 
Diethylether is gradually removed with a rotary evaporator, resulting in a suspension of 
multilamellar vesicles, which are subsequently extruded (Avanti Polar Lipids) using 100 
µm filters forming homogenous preformed liposomes of 90-130 nm diameter 
(confirmed by dynamic light scattering (DLS)). The lipid concentration was adjusted 
with buffer to 8 mM.  
For reconstitution of proteins, an R value of 1 was adjusted for OG (DDM from 
proteins was not taken into account), the lipid:protein ratios were the same as in 1.2.3.1, 
the final lipid concentration was also 2.5 mg/ml. Detergent was removed as described in 
1.2.3.1. 
2.2.4 Liposome Co-flotation on a Density Gradient for Evaluation of 
Insertion Efficiency 
50 µl of VGLUT1/TF0F1 liposomes were mixed with 50 µl of 80 % Nycodenz 
(Axis Shield) in a 250 µl centrifuge tube. The mixture was overlaid with 50 µl of 30 % 
Nycodenz and 50 µl of reconstitution buffer. The density gradient was centrifuged using 
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a Sorvall ultracentrifuge (S55S rotor, 48000 rpm, 4 °C, 90 min). After centrifugation, 20 
µl fractions were taken from the top of the gradient and analysed by SDS-PAGE or 
western blot. 
2.2.5 Proteolytic Digestion for Evaluation of VGLUT1 Orientation 
Sections of membrane inserted VGLUT1 are partially accessible to proteases. In the 
inside-out orientation these sections are protected from proteolytic cleavage, whereas in 
the right side-out orientation they are digested. By comparing the amount of cleaved 
protein after proteolytic digestion to an untreated sample and proteolytically digested 
SVs, the fraction of right side-out oriented protein can be estimated.  
Proteolytic digestion reactions were performed in 20 µl final volume. 1 µg of VGLUT1 
from proteoliposomes or SVs was digested with 0.1 µg/µl trypsin (final conc.) for 1 h at 
37 °C. For the untreated sample, trypsin was omitted and replaced with liposome buffer. 
In order to estimate complete cleavage, an additional sample was trypsinised in 
presence of 1 % TritonX-100. Samples were analysed by western blotting using α-
VGLUT1 antibody directed against the C-terminus of VGLUT1. 
2.2.6 Vesicle Acidification Measurement with Acridine Orange  
Acridine orange (AO) is a pH sensitive dye. It exhibits an absorption maximum 
at 492 nm and a fluorescence maximum at 530 nm. It is a weak base and can pass 
membranes in its unprotonated form. Upon pH drop in the vesicle lumen it gets 
protonated and trapped in the vesicle due to its positive charge. Accumulating AO 
molecules in the lumen are self-quenching due to dimerization, which leads to a drop in 
absorbance and fluorescence [89]. This decrease can be used to monitor acidification of 
the vesicle lumen [68]. Acridine orange was purchased from Molecular Probes and 
stored as 1 mM stock in 30 % EtOH.  
Measurements were performed using an Aminco dual-wavelength 
spectrophotometer. The dual-wavelength technique is enabling a stable and sensitive 
readout of small absorbance changes in turbid samples [90].  
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The photometer was equilibrated at 32 °C before use. Usually, 600 - 650 µl 
buffer (10 mM MOPS, pH 7.3, 2 mM MgSO4, containing either 200 mM Glycine, or 
100 mM KCl, NaCl, KGluconate or CholineCl) were mixed in a 1 ml glass cuvette with 
50 - 100 µl of SV or liposome sample containing 10 µM AO. After a stable baseline 
was obtained, 1.2 mM ATP, 4 mM chloride (with varying counter ions), 10 mM 
glutamate, 30 mM chloride and 10 mM (NH4)2SO4 were successively added after 
obtaining a baseline for each probe. Other ions or ionophores were added at individually 
indicated concentrations. 
2.2.7 Measurement of Membrane Potential Changes across 
Vesicular Membranes with Oxonol VI 
Oxonol VI is an anionic dye used to detect changes in membrane potential. A 
positive luminal potential attracts Oxonol VI due to its negative charge which leads to 
dye accumulation in the lumen and changes in absorbance. Absorbance changes are 
believed to occur due to association of the dye with membranes, but the precise 
mechanism is not understood [91]. OxonolVI was purchased from Molecular Probes 
and stored as a 1 mM stock in EtOH. Absorbance changes at 625 nm with a reference 
wavelength at 587 nm were detected using the same Aminco dual wavelength 
spectrophotometer as for AO measurements. 
The apparatus was equilibrated at 32 °C. Initially, a stable baseline was obtained 
after mixing 600 - 650 µl buffer (10 mM MOPS, pH 7.3, 2 mM MgSO4 containing 
either 200 mM Glycine, or 100 mM K/Na/CholineGluconate) with 50-100 µl of SVs or 
liposomes and 15 µM OxonolVI. 1.5 mM ATP, 10 mM glutamate, 30 mM chloride, 10 
mM (NH4)2SO4 and 50 µM FCCP were gradually added. A baseline was obtained 
before adding the subsequent probe. Other ions or ionophores were added at 
individually indicated concentrations. 
2.2.8 3H-Glutamate Uptake into SVs and Proteoliposomes 
Glutamate uptake into SVs and proteoliposomes was detected by radiolabelled 
3H-glutamic acid (GE). The uptake was measured in presence of 4 mM ATP, 50 µM K-
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glutamate or Choline-glutamate, 4 mM chloride and 2 µCi 3H-glutamic acid per data 
point.  
The uptake buffer contained 10 mM MOPS, pH 7.3, 2 mM MgSO4 and 100 mM 
of KGluconate or 200 mM Glycine. The reaction was started by mixing 50 - 100 µl 
SVs/proteoliposomes with 10 x uptake buffer and incubating for 20 min at 32 °C. 
Pipetting the reaction mixture into 3 ml of ice cold uptake buffer and filtering through a 
0.45 µm nitrocellulose filter stopped the reaction. The nitrocellulose filter was washed 3 
times with 3 ml ice cold uptake buffer and the remaining radioactivity trapped on the 
filter was detected by liquid scintillation. For SVs, typically 15-20 µg of total protein, 
and for proteoliposomes, 10 µg VGLUT1 were assayed per data point.  
2.2.9 General Methods 
2.2.9.1 SDS-PAGE and Coomassie Blue Staining 
10 % Polyacrylamide gels were prepared as described in [92]. After sample 
separation by electrophoresis gels were stained with Coomassie Brilliant Blue R250 in 
50 % methanol and 10 % acetic acid for 20 min. Destaining was performed using 50 % 
ethanol and 10 % acetic acid for 15 min and subsequently 10 % ethanol and 5 % acetic 
acid for 1 hour. 
2.2.9.2 Western Blotting 
After SDS-PAGE gels protein transfer on a nitrocellulose membrane was 
performed as described in [93]. The membrane was blocked in TBS-Tween (0.05 %) 
plus 5 % milk powder (w/v) (blocking solution) for 1 hour at room temperature 
followed by addition of primary antibodies diluted in the same blocking solution. 
Antibodies used in this work were VGLUT1 (1:5000 dilution), synaptobrevin II (1:1000 
dilution), SNAP25 (1:1000 dilution), all from Synaptic Systems and EF0F1 α-b-subunit 
(1:1000) from Abcam. After primary antibody incubation, membranes were washed 3 x 
5min with blocking solution and incubated with HRP-conjugated secondary antibody 
(1:2000 dilution) for 45 min. The membranes were again washed 3 x 5min and 
visualised with a Western Lightning Ultra chemiluminescence kit according to the 
manufacturer’s instruction (Perkin Elmer) using a LAS1000-reader (Fujifilm). 
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2.2.9.3 Molecular Cloning 
Mus musculusVGLUT1 DNA optimised for expression in Trichoplusia ni 
(High5) was synthesised by GeneArt. Cloning was performed using the Gateway 
cloning system according to the manufacturer’s protocol (Invitrogen). In brief, 
VGLUT1 DNA was inserted into pENTR/D-TOPO vector and by subsequent 
recombination reaction into the destination vector of choice. Destination vectors used 
were pDEST10 (His6 tag included) and pDEST8 (no tag included), both for insect cell 
expression, and pcDNA6.2 for mammalian cell expression. The N-terminal SBP tag 
was introduced by PCR.  
2.2.9.4 Electron Microscopy 
Electron microscopy of liposomes using negative staining was done as described 
in [94] and performed by Dietmar Riedel.  
2.2.9.5 Size Distribution Analysis by FFF-MALLS 
Field-flow-fractionation (FFF) coupled to a multiangle laser light scattering 
(MALLS) detector was used to determine liposome size distribution according to [95] 
and was performed by Matias Hernandez.  
2.2.9.6 Size Distribution Analysis by DLS 
Size and distribution of liposomes can also be determined by DLS. Particles in 
solution undergo Brownian motion which is depending on their size and weight. Thus, 
information on size and molecular weight of particles can be obtained from the intensity 
of scattered light as a function of time [96]. Liposomes were measured in 20 µl cuvettes 
at 30 °C in a DynaProTitan device (Wyatt Technology). Average radius was determined 
from 10 x 10 sec measurements.  
2.2.9.7 Fluorescence Dequenching for Lipid-Mixing Measurements 
SNARE-mediated fusion of TF0F1/ΔN liposomes (ΔN complex consists of 
syntaxin, SNAP25 and a short stabilising fragment of synaptobrevin49-96[97]) and SVs 
was monitored by a lipid-mixing assay. In this assay, lipids of the Q-SNARE containing 
liposomes (TF0F1/ΔN liposomes) were labelled with a self-quenched Förster resonance 
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energy transfer (FRET) pair (Nitrobenzoxadiazole (NBD) and Rhodamine (RHO)). 
Upon fusion with a non labelled R-SNARE containing sample (SVs) the labelled lipids 
were diluted expanding the distance between donor (NBD) and acceptor (RHO) dye. 
The cumulative donor - acceptor distance resulted in an increase of the donor dye 
fluorescence (NBD), which was monitored as a function of time [98] [99] [97]. The 
liposome – SV fusion reaction was measured with a spectrometer (Fluoromax-2) at an 
excitation wavelength of 460 nm and an emission wavelength of 538 nm at 30 °C in a 1 
ml quartz cuvette. The reaction was started by mixing 50µl of TF0F1/ΔN liposomes with 
10 µl SVs (~6 µg/µl) in reconstitution buffer and stopped by addition of 0.05 % 
TritonX-100 (final conc.). Fluorescence signals were normalised to the maximum 


















3.1 VGLUT1 Purification 
To study VGLUT1 transport mechanism in a minimal reconstituted system, 
single components had to be obtained in quantities, amenable for post-purification 
analysis.  
High level expression of mammalian multispanners such as transporters still 
marks the major bottleneck for protein studies today. Expression in bacterial systems is 
particularly problematic due to impairment of cellular physiological functions by 
insertion into membranes, misfolding and lack of posttranslational modifications 
required for the activity of transporters [100] [101]. Expression systems most suitable 
for membrane protein (MP) expression are insect or mammalian cell hosts [100] [102]. 
Another emerging system is cell-free expression which bypasses cellular toxic effects 
caused by the expression of challenging heterogenous proteins. Previus reports of 
successful expression of functional mammalian multispanners [103, 104] were taken 
into account in order to attempt derivation of VGLUT1 using this method. Insect cell 
expression and purification of His6-tagged rat VGLUT2 has also been described and 
was taken as another reference for mouse VGLUT1 expression work along with the 
cell-free expression [62]. Lastly, mammalian cell expression of mouse VGLUT1 was 
additionally attempted in order to isolate a protein of higher activity due to an alleged 
low activity of VGLUT1 derived from insect cells [21]. 
3.1.1 Cell-Free Expression 
The unique feature of cell-free (CF) expression is the possibility to control 
several variables and to individually optimize conditions to the requirements of each 
protein. In addition, toxic effects often caused by membrane proteins are circumvented. 
The hydrophobic environment required for MPs can be provided by direct expression 
into detergent micelles (D-CF) or even preformed liposomes (L-CF). In should be 
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considered that detergents can only be used up to certain concentrations as some are 
incompatible with the method [105]. 
The most powerful extract source, containing ribosomes and other translation 
factors currently used is E.coli S30 extract, which is not performing posttranslational 
modifications or eukaryotic folding [82]. However, the system allows supplementation 
with chaperones or co-factors for protein stability [106]. 
3.1.1.1 Cell-Free Expression of VGLUT1 
For the CF expression setup the S30 E.coli extract was isolated and the T7 RNA 
polymerase was purified. The bacterial strain and plasmid including the isolation 
protocols was obtained from Frank Bernhard’s group at the University of Frankfurt. 
Figure 3.8 shows a typical purification profile of the T7 RNA polymerase.  
 
Figure 3.8 T7 RNA Polymerase purification. (a) Purification of the T7 RNA Polymerase 
(100kDa) by anion exchange chromatography using a MonoQ HR10/10 column. Elution 
fractions 20-27 were pooled and concentrated. (b) Concentration of elution fractions was 
estimated by comparing with bovine serum albumin (BSA) and resulted in approximately 
2.5mg/ml.  
 
Several components of the reaction and feeding mixture can be varied in order to 
optimize expression. Initially, expression of green fluorescent protein (GFP) and a 
control MP could be established confirming that the setup of the system including the 
purified E.coli extract and the T7 RNA polymerase was fully functional. Subsequent 
trials on expression of VGLUT1 using a pET28a(+) vector with His10-tagged rat 
VGLUT1 were indeed successful, as confirmed by western blot analysis. However, 
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despite several optimization approaches the expression yields did not exceed 60µg/ml 
(fig.3.9). Taking into account that 1ml of reaction mixture already represents a large 
scale production volume and that purification of the protein includes additional yield 
loss, the initial expression screens were not promising enough to conduct further 
optimizations like D-CF or supplementation with chaperones. Thus, CF expression was 
no longer followed. 
Figure 3.9 CF expression of VGLUT1. (a) Western blot analysis of VGLUT1 expression levels 
with varying expression conditions is depicted. A VGLUT1 antibody directed against the C-
terminus was used. Synaptic vesicles (SVs) were loaded to estimate the amount of VGLUT1. 
The expressed protein was found in the pellet as no detergent was added to the reaction setup. 
(b) Coomassie blue staining of the varying expression conditions. VGLUT1 cannot be identified 
as a prominent band unlike the control membrane protein.  
 
3.1.2 Expression and Purification of VGLUT1 using Insect Cells 
The baculovirus expression system was used to express VGLUT1 in insect cells. 
This system is based on the application of recombinant baculoviruses, which contain 
genes (polyhedrin and p10) under the control of strong promoters. Replacement of these 
genes with the gene of interest induces expression of heterologous proteins resulting in 
high yields. A key benefit of using higher eukaryotes instead of bacteria for expression 
is its membrane composition and posttranslational modifications which resemble native 
mammalian modifications and therefore often result in biologically active protein. 
However, for more intricate proteins like transporters the higher expression rates may 
be detrimental because the vast amount of protein cannot be processed in the 
endoplasmic reticulum (ER) fast enough, resulting in protein misfolding. Partial 
enhancement of processing can be achieved by co-expression of ER molecular 
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chaperones like calnexin or calreticulin [107] and by slowing down expression by using 
the weaker promoter p10 instead of polyhedrin [108]. The process of N-glycosylation in 
insect and mammalian cells is also different which could lead to structural changes in 
glycosylation [109]. 
For the establishment of the insect cell expression system we made use of the 
commercially available donor plasmid pDEST10 containing a His6-tag, as well of the 
bacmid originally engineered by Imre Berger (ETH, Zürich) for multiprotein complex 
expression. A convenient attribute of this bacmid is the linkage of yellow fluorescent 
protein (YFP) to the expression of the protein of interest which allows measuring 
expression levels peak by recording YFP fluorescence. 
Insect cells were transfected with His-tagged mouse VGLUT1 containing 
bacmid. After obtaining a sufficient titer of virus Trichoplusia ni (High5), insect cells 
were infected and protein expression was monitored by YFP fluorescence and further 
verified by western blot analysis. Protein expression peaked at 36h-48h post infection 
(PI) (fig.3.10). As cell lysis continued beyond 48 h PI protein degradation 
predominated. Typically, an expression yield of 10 mg/l of High5 cell culture was 
obtained. 
 
Figure 3.10 Expression of VGLUT1 in insect cells. (a) Expression of YFP was monitored 
within 60h post infection (PI) representing the expression levels of VGLUT1. (b) Expression 
levels of VGLUT1 analysed by Western Blot using a VGLUT1 antibody directed against the C-
terminus. Amount of VGLUT1 was estimated by signal comparison with native VGLUT1 in SVs. 
 
3.1.2.1 Solubilisation of VGLUT1 
For a highly hydrophobic protein like VGLUT1 it is inevitable to make use of 
detergents in order to solubilise it in an aqueous environment. Detergents are 
amphipatic molecules containing a polar headgroup and a hydrophobic chain and can 
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form micelles in aqueous solution above a certain concentration (cmc). The cmc 
decreases with the length of the alkyl chain. Importantly, the detergent has to have a 
mild effect on the maintenance of protein activity which mostly applies to non-ionic or 
zwitterionic detergents as they preferentially intrudes protein-lipid and lipid-lipid 
interactions more than protein-protein interactions. Further beneficial detergent 
properties are easy removal by dialysis or size exclusion chromatography and proper 
solubilisation of protein. Most of the time one has to compromise between one or the 
other property [110]. 
In order to find the most suitable detergent for solubilisation of VGLUT1 a 
screen involving structurally diverse non- or zwitterionic non-denaturing detergents was 
performed. n-Dodecyl-β-D-glucopyranoside (DDM) turned out to solubilise VGLUT1 
best to about 50% of total expressed protein (fig. 3.11 ). DDM is a non-ionic detergent 
with a lipid-like structure known to be gentle and therefore appropriate for preserving 
VGLUT1 activity. However, its low cmc of 0.15mM and a micellar size corresponding 
almost to the protein size, complicated downstream applications. In order to completely 
exchange all native protein:lipid interactions to protein:detergent interactions a 
protein:detergent minimal ratio of 1:10 was chosen. Solubilisation times exceeding 1h 
did not enhance solubilisation effiency. 
 
Figure 3.11 Solubilisation of VGLUT1 from insect cells. Immunoblot detection of VGLUT1 
after solubilisation of insect cell membranes for 1h in presence of 2% (w/w) DDM (molecular 
structure depicted on the right taken from piercenet.com) or n-Octyl-β-D-Glucopyranoside (OG). 
Equal volumes were loaded.  
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3.1.2.2 Affinity Purification of His6-tagged VGLUT1 
Attempts to obtain enriched VGLUT1 resulted in highly contaminated elution 
fractions without a prominent VGLUT1 band. Elution using a continuous imidazole 
gradient did not improve purity of elution fractions (fig. 3.12). 
The first description of the purification of VGLUT with a His6-tag was used as 
reference for the purification attempted here [62]. However, the His6-tag only displays 
an affinity for Ni2+ in the higher micromolar range indicating that less prominently 
overexpressed proteins, like VGLUT1, will not bind with a high specificity, especially 
by taking into account the natural abundance of Histidine clusters in endogenous 
proteins. Despite the previously published His6-tag purification method a tag with a 
higher specificity towards its matrix was found to be imperative. 
 
Figure 3.12 Purification of His6-tagged VGLUT1 from insect cells. Coomassie blue staining 
and immunoblot analysis of the elution profile from a HisTrap column using a continuous 
Imidazole gradient. 1/2000 of input, flow through and wash and 1/50 of the elution fractions 
(numbered) were loaded. SV VGLUT1 was used to evaluate the amount of protein. 
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3.1.2.3 Affinity Purification of Streptavidin Binding Peptide (SBP)-tagged 
VGLUT1 
In 2001, a novel tag with a 2.5 nM affinity to Streptavidin was decribed [84]. 
The Streptavidin Binding Peptide (SBP)-tag is 38 amino acids long resulting in a 
molecular weight of ~5 kDa, thus, much smaller than alternative tagging methods such 
as Maltose Binding Protein (MBP, 40 kDa)- or Glutathion S-Transferase (GST, 26 
kDa)-tag which display comparable affinities.  
Based on previous reports, affinity purification of SBP-tagged VGLUT1 was 
attempted [21]. SBP-tagged VGLUT1 expressed similarly well as His-tagged VGLUT1 
in insect cells. Direct solubilisation of the cells using 2 % DDM and subsequent 
incubation with Streptavidin beads resulted in fairly pure elution fractions (fig.3.13a). 
Maximum yield of protein obtained was 1 mg of insect cell expression culture 
corresponding to 10 % of total expressed protein and 20 % of the soluble protein 
fraction. 
Figure 3.13 Purification of SBP-tagged VGLUT1 from insect cells. (a) Coomassie blue 
staining and immunoblot of the purification profile using Streptavidin beads. 1/100 of the elution 
fractions and beads and 1/5000 of the rest fractions was loaded. Concentrated VGLUT1 
corresponds to 5 µg of protein. (b) Size exclusion chromatography of affinity purified VGLUT1 
using a Superdex 75 16/60 column.  
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3.1.2.4 Size Exclusion Chromatography of VGLUT1 
To evaluate the protein dispersity of VGLUT1 a second purification step with 
size exclusion chromatography was performed. The elution peak was both symmetrical 
and sharp indicating a monodisperse protein-detergent complex. [111] (fig.3.13b). For 
reconstitution experiments, however, the additional purification step was not deemed 
necessary. 
3.1.3 Expression and Purification of VGLUT1 using Mammalian 
Cells 
Expression of VGLUT1 in mammalian cells was pursued in the later stages of 
this work after the activity of VGLUT1 derived from insect cells did not fulfil the 
requirements for certain measurements (section 3.3.2.5). Expressing a protein in a near-
native environment was expected to result in less protein misfolding and better 
resemblance of posttranslational modifications. 
Experiments with rat VGLUT1 expressed in HEK293 cells were performed 
earlier [21]. The expression development attempted here was based on this protocol. 
SBP-VGLUT1 was cloned in the pcDNA6.2 mammalian expression vector. 
Transfection efficiencies ranged between 20-40 % as monitored by parallel GFP 
transfection. Ca3(PO4)2 is generally less efficient than Lipofectamine (Invitrogen) 
transfection, which would have been too costly for the required expression scale. 
Regardless of transfection efficiencies, the expression levels in HEK293 cells were 
lower than in insect cells, as had been anticipated. A peculiar difference is the band 
pattern of VGLUT1 where the VGLUT1 band appears more smeared than in insect cells 
suggesting a different glycosylation pattern. Interestingly, the band pattern of native 
VGLUT1 corresponds rather to insect cell derived VGLUT1 than to HEK cell derived 
VGLUT1 (fig.3.14c). HEK cell derived VGLUT1 appeared to be N-glycosylated in 
contrast to insect cell derived VGLUT1 (fig.3.14c). The maximum yield which could be 
obtained from 1 l of cell culture was 100 µg, but varied because of differential 
transfection efficiencies. 
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Figure 3.14 Purification of SBP-tagged VGLUT1 from mammalian cells. Immunoblot using a 
C-terminal antibody (a) and coomassie blue staining (b) of the affinity purification profile of 
VGLUT1. 1/20 of the elution fractions and beads and 1/5000 of the remaining fractions were 
loaded. Concentrated VGLUT1 corresponds to 10 µg of protein. (c) Peptide N-Glycosidase F 
(PNGaseF) treated VGLUT1 expressed in insect and mammalian cells compared to untreated 
(ctrl) and native VGLUT1 from rat SVs. PNGaseF cleaves N-glycans from glycoproteins. 
 
3.2 Purification of Proton Pumps and Acidification 
Vesicular neurotransmitter transporters are secondarily active requiring an 
electrochemical gradient (ΔµH+) to energize neurotransmitter transport. ΔµH+ consists 
of the pH gradient (ΔpH) and the membrane potential (ΔΨ) formed across the 
membrane (section 1.4). ΔµH+ can be generated by ion gradients in combination with 
ionophores such as valinomycin or nigericin [112]. Unfortunately, the induced ΔpH or 
ΔΨ is short-lived constraining its application. Furthermore, it is possible to use 
bacteriorhodopsin as a light-driven proton pump [113]. However, due to its light 
sensitive-activity it is delicate to use for fluorescence based experiments. The most 
feasible energizing components are bacterial ATP synthases which synthesize ATP 
from ADP and inorganic phosphate (Pi) using a proton gradient. They are highly 
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abundant and accessible to purification and in the presence of ATP they generate ΔµH+ 
by hydrolysing ATP. 
3.2.1 Purification of E.coli ATP Synthase (EF0F1)  
The first proton pump tested was an ATP synthase from E.coli provided by Peter 
Gräber (University of Freiburg). They routinely use EF0F1 to study ATP synthesis rates 
and have an established purification protocol [114]. A typical elution profile of a EF0F1 
purification after the last size exclusion chromatography step is depicted in figure 3.15a.  
Figure 3.15 Purification and acidification properties of EF0F1. (a) Elution profile of EF0F1 
from the final size exclusion step using a Superdex 200 HiLoad 26/600 column. 1/200 of the 
elution fractions were loaded. (b) Acidification of EF0F1 liposomes upon addition of ATP. NH4
+ 
ions form a dynamic equilibrium. NH4
+  NH3 + H
+. Whilst NH4
+ is not membrane permeable 
due to its charge NH3 is and therefore diffuses into the SV lumen where the equilibrium is 
shifted back to NH4
+ ions due to NH3 excess neutralising the pH.  
  
 
3.2.2 Electrogenic Properties of EF0F1 in Reconstituted Liposomes 
EF0F1 reconstituted liposomes did not exhibit tight ionic coupling. 
Bioenergetically, acidification of the liposome lumen upon addition of ATP is arrested 
due to the lack of a shunt which provides counter ion flux for H+. Thus, a large 
membrane potential across the liposome membrane is generated (fig. 1.3). Once an ion 
shunt is present, e.g. valinomycin, an ionophore which is highly selective for K+, a 
counter ion flux enables EF0F1 to acidify the liposome lumen in the presence of luminal 
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K+ (fig. 1.3). Yet, in EF0F1 proteoliposomes a strong acidification was observed even 
without addition of an ionophore, indicating leakage of the liposomes (fig.3.15b).  
3.2.3 Properties of Liposomes 
In order to find the source of leakage, the properties of EF0F1-free liposomes 
containing VGLUT1 (for reproducibility) were studied in the presence of different 
ionophores. First, an outwardly directed K+ gradient in liposomes was created by 
encapsulating K+ into the liposomes and exchanging the external buffer to K+-free 
buffer. If the liposomes are impermeable to K+ and H+, addition of valinomycin alone 
will not mediate acidification due to a lack of counter ion flux. As soon as counter ion 
flux is induced by addition of the H+ ionophore Carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone (FCCP) the K+ gradient drives liposome acidification 
(fig. 3.16b). This was observed by successive addition of the mentioned ionophores 
(fig.3.17a), strongly indicating that the liposomes are not K+ or H+ permeable. 
Nigericin is a H+/K+ antiporter, merging the function of valinomycin and FCCP. 
The stability of the signal upon addition of nigericin to liposomes with an outwardly 
directed K+ gradient represents the leakage properties of the liposomes with regard to 
K+ and H+ ions. The acidification signal after addition of nigericin in figure 3.17b does 
not realkalinize, further supporting the view that the liposomes are non-leaky. 
In addition to the acidification, ΔΨ changes were measured in the presence of 
valinomycin using Oxonol VI as a ΔΨ-sensitive dye. In intact liposomes with an 
inwardly directed K+ gradient, supplementation with valinomycin forms a stable ΔΨ 
(fig. 3.16).  
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Figure 3.16 Illustration of ΔΨ and ΔpH formation in liposomes by artificial gradients. a) 
An inwardly directed K+ gradient in the presence of the K+ ionophore valinomycin generates an 
inside positive ΔΨ by K+ influx. b) An outwardly directed K+ gradient in the presence of 
valinomycin and the H+ ionophore FCCP acidifies the liposome lumen by efflux of K+ and influx 
of H+. c) An outwardly directed K+ gradient in the presence of the K+/H+ antiporter nigericin 
evokes acidification of the liposomes by the same principle as in b).  
 
The stability of the generated ΔΨ is thus an indirect way to display the quality of 
the liposomes. Figure 3.17c-d illustrates the impact of valinomycin concentration on 
membrane integrity and exhibits a stably maintained ΔΨ in liposomes with a certain 
valinomycin concentration. The performed measurements suggest that liposomes retain 
their structural integrity meaning that the occurring leakage in EF0F1 proteoliposomes is 
probably caused by the presence of EF0F1 and not by any permeability of the 
membrane. 
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Figure 3.17 Properties of VGLUT1 liposomes regarding ion leakage. (a-b) Acidification of 
proteoliposomes upon addition of ionophores. (c-d) Membrane potential increase and stability in 
proteoliposomes with varying concentrations of Valinomycin. VGLUT1 was inserted to exclude 
leakage originating from VGLUT1. Val= Valinomycin, Nig= Nigericin. 
 
3.2.4 Purification of His-tagged F0F1 (TF0F1) from Bacillus 
thermophilus 
EF0F1 proteoliposomes did not display tight ionic coupling which was required 
for the ΔµH+ based measurements. An alternative approach for the energizing 
component had to be pursued. 
A His6-tagged construct of a F0F1 ATP synthase from Bacillus thermophilus was 
previously used as proton pump [21]. The E.coli DK8 strain carrying the pTR19ASDS 
plasmid was obtained from Masasuke Yoshida (Tokyo Institute of Technology/Japan) 
[80]. 
The purification protocol was adapted from [21] In figure 3.18 the elution 
profiles after affinity purification and anion exchange illustrate highly enriched protein 
complex, which is separated into its subunits already after the affinity purification step 
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and additionally enriched in the subsequent purification steps. One purification typically 
yielded ~6 mg of protein from 2 l of expression culture. 
Figure 3.18 Purification of TF0F1. (a) Elution profile of TF0F1 affinity purification using Talon 
beads. (b) Coomassie Blue staining of anion exchange chromatography elution fractions using 
a MonoQ HR5/5 column. (c) Elution profile of the anion exchange chromatography. Absorbance 
at 280 nm was measured. 
 
3.2.5 Electrogenic Properties of TF0F1 
Reconstitution of TF0F1 into liposomes and subsequent activity analysis revealed 
that activity and impermeability properties were excellent. TF0F1 did not acidify the 
liposomes until the addition of valinomycin which permits an efflux of K+ (fig 3.19). 
This further confirmed the integrity of the generated proteoliposomes. 
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Figure 3.19 Activity of TF0F1 proteoliposomes. (a-b) Acidification upon addition of ATP and 
Valinomycin in +TF0F1 (a) and –TF0F1 (b) liposomes. (c) Membrane potential response to ATP 
and Valinomycin in TF0F1 liposomes. Val= Valinomycin. 
 
3.3 Co-Reconstitution of VGLUT1 Derived from Insect Cells 
and TF0F1 
After successfully purifying VGLUT1 from insect cells and acquiring a fully 
functional proton pump co-reconstitution into liposomes was next attempted. Distinct 
techniques have been established to produce proteoliposomes. Essentially, there are two 
approaches which can be pursued. One is to use preformed liposomes which are 
supplemented in a second step with proteins and detergent for direct insertion into the 
bilayer (direct method), while the second consists of mixing lipids, proteins and 
detergent followed by removal of the detergent giving rise to spontaneous insertion and 
liposome formation (co-micellisation method) [86].  
Depending on the detergent, it can either be removed by dilution (e.g. dialysis) 
or by size exclusion chromatography. BioBeads are macroporous adsorbents with a high 
surface area and can also be used for detergent removal [110]. 
For co-reconstitution into liposomes with VGLUT1 and TF0F1 the presence of 
DDM in the protein stock solution has to be taken into account. DDM cannot be readily 
removed by dialysis due to its low cmc and high aggregation number. However, 
   43
Results 
BioBeads are capable of adsorbing DDM and cyclodextrin, a cyclic oligosaccharide, has 
been reported to complex DDM [87]. 
Lipids were dissolved in n-octyl-β-D-glucopyranosid (OG), a short chain non-
ionic detergent that, used in higher concentrations, can harm the biological activity of 
proteins. For co-reconstitution purposes the concentration therefore needed to be kept as 
low as possible. 
Biological membranes are mainly composed of Phosphatidylcholine (PC), the 
most abundant phospholipid, Phosphatidylserine (PS), Phosphatidylethanolamine (PE), 
Phosphatidylinositols (PIs) and Cholesterol. The lipid composition shapes the bilayer 
architecture and can therefore dramatically affect protein structure and function [115]. 
The ideal liposome composition would mimic the native environment of the protein 
although the presence of lipid microdomains makes it difficult to actually determine the 
“native” environment of a specific protein.  
For experimental applications synthetic lipids mimicking natural phospholipids 
are available. The benefit of synthetic lipids is the chemical consistency whereas natural 
lipid extracts exhibit differences that are preparation-dependent. 
3.3.1 Co-Reconstitution of VGLUT1 and TF0F1 by the Co-
Micellisation Method with Lipids from Soybean Extract 
Initially, liposomes were formed by the co-micellisation method using lipid 
extract from soybeans (containing mainly PC) and cholesterol in a ratio of 80:20. The 
protein:lipid ratios were adjusted to 1:25 for VGLUT1 and 1:50 for TF0F1 [21]. Lipid 
stocks dissolved in OG and proteins dissolved in DDM were mixed and detergent was 
removed by dialysis and addition of spheric macroporous adsorbens (BioBeads) to 
enhance detergent removal. After complete removal of OG, proteoliposomes were 
supplemented with cyclodextrin to complex residual DDM. The resulting 
proteoliposomes were then characterized with regard to incorporation efficiency, 
orientation of the proteins and size distribution. 
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3.3.1.1 Incorporation of Proteins into Liposomes Generated by the Co-
Micellisation Method 
Incorporation efficiency was determined by centrifuging the proteoliposomes at 
high g forces in a density gradient and determining the fraction of protein that co-floated 
along with the low-density liposomes, while any unincorporated protein remains at the 
bottom of the gradient due to its higher density. VGLUT1 incorporated efficiently into 
liposomes most likely due to its strong hydrophobic character (fig. 3.20). Nonetheless, 
although care was taken to remove detergent as completely as possible, the presence of 
remaining detergent micelles cannot be fully excluded.  
TF0F1 incorporation was likewise successful. Western blot analysis directed 
against the β-subunit of TF0F1 confirmed that it co-floated with the liposome fractions. 
Interestingly, in the corresponding coomassie stain a band was observed throughout the 
entire density gradient, supposedly representing the detached headgroup of TF0F1 (fig. 
3.20). 
 
Figure 3.20 Co-flotation analysis of VGLUT1/TF0F1 liposomes generated by the co-
micellisation method. Equal volumes of gradient fractions were loaded and detected for 
VGLUT1 and TF0F1 using immunoblot and coomassie blue stain analysis. Liposome fractions 
were identified by a turbid ring forming at the top of the gradient.  
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3.3.1.2 Orientation of Proteins in Liposomes Generated by the Co-
Micellisation Method 
The right-side out orientation of the MPs is crucial for their proper function. The 
composition of lipids as well as the type and concentration of detergent, can affect the 
final orientation. To check for orientation, VGLUT1 liposomes were trypsinised and 
detected with an antibody directed against the C-terminus. If VGLUT1 tails are oriented 
into the liposome lumen (inside out orientation), the bilayer will protect the epitope and 
the signal will still be detectable. However, if the tails are oriented right-side out, 
trypsin will cleave the epitope and the signal vanishes. In liposomes digested by trypsin 
no VGLUT1 signal was detectable indicating that the protein is entirely inserted in the 
right-side out direction (fig. 3.21a). Partial influx of trypsin into the liposome cannot be 
fully excluded, however, the integrity of the generated liposomes towards several ions 
(section 3.2.3) suggests this is unlikely. 
Right-side out orientation of TF0F1 was determined by liposome acidification 
measurements as described in section 3.2.5. 
3.3.1.3 Size Distribution in Liposomes Generated by the Co-Micellisation 
Method  
Liposome size distribution was quantitatively analysed by Field Flow 
Fractionation coupled to Multi-Angle laser light scattering (FFF-MALLS) and 
qualitatively by electron microscopy (fig. 3.21b-c). The peak diameter of the liposomes 
determined by FFF was 160 nm. Electron microscopy revealed a very broad size range 
of the formed liposomes from 50-300 nm. Moreover, it is possible to see the headgroups 
of the TF0F1 located on the membranes which are partially inhomogeneously distributed 
on the liposome surface. 
   46
Results 
 
Figure 3.21 Characterisation of liposomes containing VGLUT1 derived from insect cells 
and TF0F1 generated by the co-micellisation method. (a) Orientation study of VGLUT1 by 
trypsinisation of the proteoliposomes. Control liposomes do not contain any Trypsin and the 
Trypsin+TritonX-100 lane represents full digestion of solubilised VGLUT1 liposomes. (b) Size 
distribution of proteoliposomes determined by FFF-MALLS. (c) Electron microscopy images of 
soybean extract proteoliposomes.   
 
3.3.1.4 Glutamate Uptake as Control of Proper Orientation and Biological 
Activity of VGLUT1 in Liposomes Generated by the Co-Micellisation 
Method 
A standard glutamate uptake assay with VGLUT1/TF0F1 proteoliposomes was 
performed in order to determine the activity of VGLUT1. An approximate 3-fold 
accumulation of 3H-Glutamate in liposomes containing VGLUT1 was observed, 
strongly suggesting that recombinant VGLUT1 derived from insect cells is capable of 
mediating glutamate translocation. 
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Figure 3.22 Glutamate uptake by insect cell expressed VGLUT1/TF0F1 proteoliposomes. 
Glutamate uptake under standard conditions (see Methods) into soybean extract liposomes with 
or without VGLUT1 and in the presence of the H+ ionophore FCCP. 10 µg of VGLUT1 were 
assayed per datapoint.  
 
3.3.2 Co-Reconstitution of VGLUT1 and TF0F1 by the Direct Method 
with Synthetic Lipids 
As an alternative reconstitution method liposomes were generated by the direct 
method with a defined diameter and lipid composition. This method allows studying 
effects related to the liposome diameter. Most notably, using a defined lipid 
composition the relevance of single lipid components to liposome properties and protein 
function can be estimated and the reproducibility of experiments is elevated. 
On that account, preformed liposomes with a uniform size distribution of 100 
nm (refer to methods) were used in an attempt to directly incorporate proteins. 
Furthermore, well-defined synthetic instead of crude soybean lipids were used with 
varying compositions of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-
dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) and Cholesterol. 
Preformed liposomes were permeabilised to facilitate incorporation of VGLUT1 
and TF0F1 using OG followed by detergent removal as described in section 3.3.1. Size 
and incorporation efficiency of the proteoliposomes was then determined. 
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3.3.2.1 Incorporation of Proteins into Liposomes Generated by the Direct 
Method  
Incorporation efficiency in preformed liposomes with altering 
DOPC/DOPS/Chol ratios was analysed using density gradient centrifugation as 
described in section 1.3.1.1. VGLUT1 was inserted efficiently into the liposomes 
independently of the lipid composition (fig.3.23). Incorporation of TF0F1 was 
determined indirectly by acidification measurements. 
 
Figure 3.23 Reconstitution efficiency of VGLUT1 in preformed liposomes and size 
distribution of VGLUT1/TF0F1 proteoliposomes. (a) Insertion efficiency of VGLUT1 into 
preformed synthetic lipid liposomes depending on the lipid composition analysed by co-flotation. 
(b) Proteoliposome size distribution of varying lipid compositions as measured by dynamic light 
scattering (DLS).   
 
3.3.2.2 Orientation of VGLUT1 in Proteoliposomes Generated by the Direct 
Method 
The orientation of VGLUT1 in liposomes of varying lipid compositions was 
analysed by trypsinisation and subsequent detection of the remaining epitope (fig 3.24). 
Interestingly, the insertion orientation seems to be slightly affected by the lipid 
composition. In liposomes without DOPS, VGLUT1 incorporates with inside-out 
orientation to some extent, however, the difference was considered to be largely 
negligible. 




Figure 3.24 Orientation of VGLUT1 in liposomes generated by the direct method. 
Proteoliposomes prepared from synthetic lipids were digested with trypsin in the absence and 
presence of TritonX-100. In proteoliposomes without PS, a small amount of VGLUT1 is not 
trypsinated, indicating it is oriented in the inside-out direction.  
3.3.2.3 Size Distribution of Proteoliposomes Generated by the Direct Method 
The size of the liposomes was determined by Dynamic Light Scattering (DLS), 
an alternative method to determine liposome diameter. The diameter of the 
proteoliposomes was found to be always larger than the initial diameter of the 
preformed liposomes and strongly depended on the detergent (OG) concentration used. 
This dependence can be rationalised in terms of the R value, representing the ratio of 
detergent molecules in excess of the cmc to the number of lipid molecules: 
  
R = ( [detergent] – [cmc]) / [lipids] 
 
An R value of 1 produced proteoliposomes of a size closest to the original 
100nm (fig.3.23b) and was sufficient to insert VGLUT1. OG concentration had to be 
kept low for maintaining maximal protein activity. In figure 3.23 average liposome radii 
for varying lipid compositions are depicted. Liposome radius is increasing with addition 
of Cholesterol and removal of DOPS. Most likely decreasing DOPS headgroup-
headgroup resulsion evokes clustering of liposomes.  
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3.3.2.4 Glutamate Uptake as Control of Proper Insertion of VGLUT1 in 
Liposomes Generated by the Direct Method 
VGLUT1 inserted in preformed liposomes composed of synthetic lipids 
maintained its glutamate transport activity. In figure 3.25 the dependence of glutamate 
transport on lipid composition is depicted. The most striking finding is that VGLUT1 
does not exhibit glutamate transport activity in the absence of Cholesterol.  
 
Figure 3.25 Glutamate translocation in VGLUT1/TF0F1 liposomes generated by the direct 
method using synthetic lipids. (a-c) Time course of glutamate uptake in +/- VGLUT1 
liposomes for different lipid compositions. 10µg VGLUT1 were assayed per data point. 
 
3.3.2.5 Cl- Conductance of VGLUT1/TF0F1 Proteoliposomes 
Recently, Cl- conductance by VGLUT1 in reconstituted liposomes has been 
shown [21]. By contrast, another work was published in which Cl- transport by 
VGLUT1 reconstituted in liposomes was not observed [74]. To clarify the conflicting 
results Cl- conductance by VGLUT1 was investigated using VGLUT1 liposomes 
containing TF0F1. This was attempted by monitoring Cl
- dependent acidification of the 
proteoliposome lumen in the presence of the pH sensitive dye acridine orange. If 
VGLUT1 was permeable to Cl-, supplementation with Cl- should promote acidification 
of the lumen by providing counter ions for H+. However, no Cl- induced acidification in 
liposomes containing VGLUT1 was observed (fig. 3.26). The measurements were 
conducted in K+ containing buffer ([K+]in = [K
+]out) allowing determination of TF0F1 
activity by supplementing the liposomes with valinomycin, thus facilitating exchange of 
luminal K+ for H+ from TF0F1. Taken together, TF0F1 liposomes with VGLUT1 derived 
from insect cells did not exhibit any Cl- conductance.  
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Figure 3.26 Cl- dependent acidification of VGLUT1 liposomes. (a-b) Cl- induced acidification 
in liposomes lacking (a) and containing (b) VGLUT1. TF0F1 activity control was determined by 
subsequent addition of valinomycin. 
 
3.3.2.6 Dependence of Glutamate Uptake on Luminal Cl- 
A strong enhancement of glutamate uptake in VGLUT1/TF0F1 proteoliposomes 
in the presence of high luminal Cl- has been previously shown (section 1.5.5) [21]. High 
luminal Cl- concentration originating from endocytosis of SVs is physiologically 
relevant and would promote glutamate uptake. In the VGLUT1/TF0F1 in vitro system 
without the presence of Cl- channels an enhancement of glutamate uptake strongly 
implicates Cl- transport by VGLUT1. However, any enhancing effect mediated by 
luminal Cl- was not observed in this study (fig. 3.27). This further disagrees with the 
role of Cl- conductance by VGLUT1 but not necessarily the effect of luminal Cl- on 
glutamate uptake in SVs where the Cl- conductance is mediated by Cl- channels such as 
ClC3 [116]. The luminal composition of isolated SVs is largely unknown and difficult 
to manipulate, making studies investigating the effect of luminal content on glutamate 
uptake challenging. 
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Figure 3.27 Glutamate uptake in the presence and absence of luminal chloride. Glutamate 
uptake of +/- VGLUT1 proteoliposomes with high or no luminal chloride and in presence and 
absence of FCCP. 10µg VGLUT1 were assayed per data point. 
 
3.4 Co-Reconstitution of VGLUT1 from Mammalian Cells and 
TF0F1 
In the previous sections (3.3.2.4-3.3.2.6) it was shown that VGLUT1 derived 
from insect cells exhibited glutamate uptake activity but no Cl- conductance, in contrast 
to [21] but also in agreement with [74] previous reports. Nevertheless, in order to rule 
out a lack of activity in insect cell derived VGLUT1 it was additionally expressed and 
purified from mammalian cells (fig. 3.14) as processing of mouse VGLUT1 in 
mammalian cells was anticipated to rather resemble native posttranslational 
modifications and protein folding. 
3.4.1 Co-reconstitution of VGLUT1 and TF0F1 by the Direct Method 
with Synthetic Lipids 
Mammalian cell-derived VGLUT1 was reconstituted in liposomes by the direct 
method using synthetic lipids as decribed in 3.3.2. 
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3.4.1.1 Characterisation of Liposomes Containing VGLUT1 Derived from 
Mammalian Cells and TF0F1 Generated by the Direct Method  
Figure 3.28a shows VGLUT1 insertion efficiency of approximately 95%. 
Orientation study was performed following the same procedure as in chapter 3.3.1. 
Right side out direction of VGLUT1 is displayed in figure 3.28b. The average diameter 
of the VGLUT1/TF0F1 proteoliposomes was determined using DLS (fig. 3.28c).  
3.4.1.2 Glutamate Uptake in Liposomes Containing VGLUT1 Derived from 
Mammalian Cells and TF0F1 as Control of VGLUT1 Activity 
Unlike expected, glutamate uptake of the liposomes containing mammalian cell 
derived VGLUT1 lagged behind the uptake by insect cell-derived VGLUT1 (fig.3.28d). 
Ultimately, using mammalian cell-derived VGLUT1 glutamate uptake and Cl- 
dependent acidification were not improved compared to insect cell derived VGLUT1. 
 
Figure 3.28 Characterisation of liposomes containing mammalian cell expressed VGLUT1 and 
TF0F1. (a) Insertion efficiency of VGLUT1 into preformed liposomes with DOPC/DOPS/Chol 50/25/25 
for R=1. (b) Orientation analysis of VGLUT1 by Trypsinisation. Trypsin+TritonX-100 represents the fully 
digested  VGLUT1 epitope (right and wrong side orientation) and Trypsin only represents the portion of 
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VGLUT1 epitopes pointing outwards (right side orientation). (c) Size distribution of proteoliposomes 
determined by DLS. (d) Glutamate accumulation in +/- VGLUT1 liposomes in the presence and 
absence of FCCP. 10µg VGLUT1 were assayed per data point.  
3.5 Identification of a Putative K+/H+ Exchanger Affecting the 
Bioenergetics of Glutamate Transport 
Recently, a novel finding regarding the glutamate loading mechanism was 
reported [76], with various data suggesting that a vesicular K+/H+ exchanger promotes 
glutamate uptake. However, the exchange mediating molecule could not be identified 
with certainty although Na+/H+ exchangers (NHEs) 6 and 9 as putative candidates have 
been proposed. The exchange of luminal H+ for cytosolic K+ on SVs can increase ΔΨ 
generated across the vesicle membrane and therefore enhance glutamate uptake which is 
mainly dependent on ΔΨ. Thus, it was attempted to study K+/H+ exchange and to 
identify the putative exchanger.  
3.5.1 Changes in SV ΔpH Evoked by Monovalent Cations 
A K+/H+ exchange mechanism on SVs is expected to affect ΔµH+. In order to 
investigate the presence of K+/H+ exchange on SVs, the effect of monovalent cations on 
ΔpH was analysed in an environment free of monovalent cations. For this, Na+, K+ and 
Choline+ dependent changes in luminal pH using acridine orange as pH sensitive dye 
(method described in 2.2.6) were monitored. A decrease in acridine orange absorbance 
at 492 nm represents pH drop in the SV lumen. Initially, SVs displayed Cl- and 
glutamate dependent acidification suggesting proper activity. Strikingly, 
supplementation with Na+ evoked a rapid realkalinisation of the SVs (fig. 3.29a), 
strongly indicating an exchange of luminal H+ with Na+ by enhancing luminal pH. 
Addition of K+ also evoked realkalinisation (fig. 3.29b), albeit weaker than Na+, 
whereas addition of the membrane impermeable Choline+ did not exhibit any effect on 
ΔpH (fig. 3.29c). The extent of Na+ or K+ mediated realkalinisation was dose dependent 
(data not shown). Clearly, the Na+/K+ specific response in SVs supports the described 
K+(Na+)/H+ exchange mechanism on SVs [76]. Na+ was preferred over K+ in the 
exchange with H+ (fig. 3.29a-b). However, it should be noted that K+ in the 
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H+/monovalent cation exchange mechanism is physiologically more relevant because of 
very low cytosolic Na+ concentrations [117].  
 
Figure 3.29 Monovalent cation effect in K+ free buffer. (a-c) Acidification of SVs after 
addition of 4mM chloride (Cl-) and 10mM glutamate (Glut-) and subsequent realkalinisation by 
30 mM Na+(a), K+(b) and Choline+(c). Gluconate as membrane impermeable anion was used. 
 
Cl- promotes acidification of the SV lumen by serving as counter ion for H+. The 
extent of Cl- dependent acidification depending on the cation was studied. First, KCl- 
and CholineCl- evoked acidification in SVs in buffer containing 100 mM K+ was 
monitored. It was observed that CholineCl- evoked acidification was more pronounced 
than KCl- evoked acidification (fig. 3.30a). Remarkably, in K+- free buffer the 
difference in Cl-- evoked changes on ΔpH much more drastically depended on the 
cation used (fig. 3.30b). CholineCl mediated moderate acidification of the SVs whereas 
KCl directly realkalinised SV lumen without provoking any acidification. Taken 
together, these findings provide a compelling evidence for a concentration gradient-
driven K+/H+ exchange mechanism on SVs.  
Figure 3.30 K+ dependent SV realkalinisation. (a-b) Impact of 100 mM KCl and CholineCl 
respectively on acidification of SVs in K+ -containing (a) and K+-free (b) buffer.  
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3.5.2 Changes of SV ΔΨ Evoked by Monovalent Cations 
In the previous section a K+/H+ exchange mechanism was found to affect the 
ΔpH component of ΔµH+. An exchange of luminal H+ for external K+ increases the 
luminal pH showed by K+-dependent realkalinisation (fig. 3.29 and 3.30). This enables 
TF0F1 to transport more H
+ into the SVs which is expected to increase the overall ΔΨ. 
This effect was experimentally accessed by monitoring the response of ΔΨ in SVs to 
Na+, K+ and Choline+ using the ΔΨ sensitive dye OxonolVI (method described in 2.2.7). 
Preliminary measurements using SVs in monovalent ion-free buffer show an increase in 
ΔΨ mediated by Na+ and K+. By contrast, addition of membrane-impermeable Choline+ 
did not induce any changes in ΔΨ (data not shown). These initial trials support a ΔΨ 
enhancing effect by exchange of luminal H+ with external K+.  
3.5.3 Dependence of Glutamate Uptake on K+ 
The findings in the previous sections (3.5.1 and 3.5.2) showed a dramatic effect 
of K+ and Na+ on the ΔµH+, in agreement with the work of Goh and colleagues [76]. 
VGLUTs are mainly driven by ΔΨ, thus, an increase of ΔΨ by H+/K+ exchange can 
promote glutamate uptake. Consequently, glutamate uptake in SVs was measured in 
presence and absence of K+. Clearly, an enhancing effect by K+ ions on glutamate 
uptake was detected (fig. 3.31) showing that the increase in ΔΨ by H+/K+ exchange 
enhances steady state glutamate filling, consistent with the previously published study 
[76].  
NHEs were suggested to mediate H+/K+ exchange [76]. However, in contrast to 
previous reports it was not found that the NHE inhibitor EIPA (5-(N-ethyl-N-
isopropyl)amiloride) [118], reduced glutamate uptake (fig. 3.31) as it would be expected 
for an NHE-mediated K+/H+ exchange. Therefore, identification of the molecule 
mediating K+/H+ exchange was pursued. A potential candidate was VGLUT1. Initially 
described as a Na+/PO4
3- transporter [47] [119], it is capable of transporting Na+. 
Furthermore, H+ transport by VGLUT is also discussed [70] [77].  
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Figure 3.31 K+ effect on glutamate translocation in SVs. SV standard glutamate uptake (20 
min, steady state level) was measured in the presence and absence of 100 mM K+. ΔµH+ was 
dissipated by 40 µM FCCP, VGLUT1 was inhibited by 10 µM Evans Blue and 50 µM EIPA was 
added to block putative NHEs. 20µg of total SV protein was assayed per data point.  
 
3.5.4 Enrichment of NHE6/9 in SVs 
In the previous section it was found that K+ mediated enhancement in glutamate 
uptake was not reduced by the NHE inhibitor EIPA (fig. 3.31) indicating that H+/K+ 
exchange on SVs is not driven by NHEs. However, as NHEs 6 and 9 were suggested to 
mediate H+/K+ exchange [76], their localisation and enrichment on SVs was analysed. 
NHE6 has been identified in glutamatergic and gabaergic SVs by mass spectrometry 
[120] and NHE9 which was reported to be involved in brain related disorders [121] 
[122]. 
Commercially available antibodies for NHE6 and 9 were used to detect putative 
localisation in SVs (fig. 3.32). Enrichment was not observed. However, using the NHE9 
antibody a band at ~130 kDa could be detected in SVs, not corresponding to the 
predicted NHE9 size of about 70 kDa. A faint band with the correct size of ~70 kDa 
could be detected with the NHE6 antibody. An evaluation on the quality of the 
antibodies is difficult due to a lack of positive control. 
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Figure 3.32 Enrichment of NHE6 and 9 in SVs. Immunoblot analysis of NHE6 and 9 
localisation in SV purification fractions. 40 µg total protein was loaded per fraction. Enrichment 
of Synaptobrevin in the same blot is depicted in the bottom part. 
 
3.5.5 Changes of ΔpH in Dense Core Vesicles Mediated by 
Monovalent Cations 
Dense core vesicles (DCVs) isolated from bovine adrenal glands are aminergic 
and routinely isolated in our laboratory. Hitherto, the K+/Na+ effect has only been 
studied in whole brain SVs but not in aminergic chromaffin granules without any 
VGLUTs. Hence, it was somewhat intruguing to look for a K+/Na+ mediated 
alkalinisation in those organelles. Cl- dependent acidification was very pronounced but 
an alkalinisation after addition of Na+ ions was indeed absent (fig. 3.33a). To prevent 
the powerful V-ATPase from masking the putative alkalinisation effect, ΔµH+ was 
dissipated by blocking the V-ATPase with BafilomycinA1. Subsequent addition of Na+ 
still did not induce any enhanced realkalinisation (fig. 3.33b) implicating that K+/H+ 
exchange may be a specific characteristic of glutamatergic/gabaergic vesicles or perhaps 
be mediated by VGLUT itself. 
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Figure 3.33 Monovalent cation effect in DCVs. (a) Cl- dependent acidification DCVs and Na+ 
effect. (b) V-ATPase was blocked after chloride-dependent acidification with BafilomycinA1 
which induces realkalinisation. Na+ was added subsequently. 
 
3.5.6 VGLUT1 Dependent Monovalent Cation Effect on ΔpH in SVs 
To compile more evidence for VGLUT’s K+/H+ operating mode we inhibited 
VGLUT by Evans Blue and monitored Cl- dependent acidification and Na+-dependent 
alkalinisation as described in section 3.5.1. First, Cl- dependent acidification and Na+ 
induced realkalinisation in SVs in absence of Evans Blue was monitored (fig. 3.34a). 
Addition of Evans Blue did not inhibit Cl- dependent acidification but it dramatically 
inhibited the alkalinisation mediated by Na+ (fig.3.34a-b). Blocking of V-ATPase by 
Bafilomycin induced realkalinisation of the vesicle lumen and was accelerated upon 
Na+ addition. However, in the presence of Evans Blue the stimulating effect of Na+ 
vanished (fig.3.34c-d). Suppression of Na+-induced alkalinisation by Evans Blue 
strongly indicated that VGLUT1 is involved in Na+(K+)/H+ exchange. 
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Figure 3.34 VGLUT1 dependent effect on Na+/K+ induced realkalinisation. (a-b) Cl- 
dependent acidification and Na+ dependent realkalinisation in the presence and absence of 10 
µM Evans Blue. (c-d) Evans Blue-dependent Na+ induced realkalinisation after V-ATPase 
inhibition with BafilomycinA1. 
 
3.5.7 VGLUT1 Dependent Monovalent Cation Effect on ΔΨ in SVs 
Inhibition of VGLUT1 by Evans Blue suppressed Na+ evoked pH increase in 
SVs indicating that VGLUT1 is mediating H+/Na+ exchange. Consequently, the 
inhibition of VGLUT1 was expected to suppress Na+ evoked increase in ΔΨ which was 
observed in preliminary measurements in section 3.5.2. Na+ mediated changes in ΔΨ in 
presence and absence of Evans Blue were monitored using OxonolVI as ΔΨ sensitive 
dye (method described in 2.2.7). Preliminary ΔΨ measurements are depicted in figure 
3.35. First, Cl- induces a drop in ΔΨ, consistent with the decrease in luminal pH (fig. 1.3 
and 3.34). This drop was independent of Evans Blue indicating maintained SV function. 
Remarkably, Na+ mediated increase in ΔΨ was inhibited in the presence of Evans Blue. 
Altogether, the inhibiting effect of Evans Blue on Na+/K+ induced changes in ΔΨ 
substantially reinforce VGLUT1 as a key player involved in K+/H+ exchange.  
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Figure 3.35 VGLUT1 dependent Na+ effect on ΔΨ. (a-b) Na+ induced changes in SVs in 
absence (a) and presence (b) of Evans Blue. 
 
3.6 Study of VGLUT Function using “Fused SVs” 
As already mentioned previously manipulation of the vesicular lumen is a 
challenging task which has not been satisfyingly resolved. “Fused SVs” as a novel and 
promising approach addressing this issue were used to study VGLUT1 function.  
The approach is based on previously published work, in which liposomes 
reconstituted with syntaxin 1/SNAP-25, the plasma membrane components of the core 
fusion machinery, were shown to efficiently fuse with SVs [123]. Generation of such 
“fused SVs” provides a unique way to modify SV luminal composition by preloading 
the proteoliposomes with defined components. For this purpose, the proteoliposomes 
containing syntaxin 1 and SNAP-25 were additionally co-reconstituted with TF0F1 as 
external energy source and fused with SVs. By selectively inhibiting the native SV V-
ATPase with Bafilomycin A1 only fused SVs which are energized by TF0F1 with 
accordingly modified content are addressed in the measurements.  
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Figure 3.36 Schematic representation of fusion SV formation. Liposomes containing 
Syntaxin (red line) and SNAP25 (green lines) with a short stabilising Synaptobrevin fragment in 
addition to TF0F1 fuse with SVs containing Synaptobrevin (blue line) which is displacing the 
stabilising short fragment. V-ATPase of SVs is blocked by Bafilomycin excluding non-fused 
vesicles from measurements. 
 
Another characteristic of fused SVs is the more physiological environment of 
VGLUT1. Unlike in the in vitro system containing only VGLUT1 and a bacterial pump, 
the function of VGLUT1 is studied in presence of all additional vesicular components. 
However, intrinsic VGLUT functions are difficult to study with this method. 
Preliminary characterisation of this approach will be described.  
3.6.1 Co-Reconstitution of the Fusion ΔN Complex and TF0F1 by the 
Direct Method 
Liposomes containing SNAP25 and Syntaxin 1 with a short stabilising C-
terminal fragment of Synaptobrevin (ΔN complex) [97], and TF0F1 were generated by 
the direct method. Preformed liposomes were doped with OG at R=1 and detergent was 
subsequently removed by dialysis and additional supplementation with BioBeads. The 
insertion efficiency of the ΔN complex was analysed by co-flotation with liposomes and 
accounted for ~80 % (fig. 3.37a). Remarkably, the ΔN/TF0F1 proteoliposomes acidified 
in the presence of ATP and the K+ ionophore valinomycin suggesting proper TF0F1 
insertion and maintenance of thighly coupled activity (fig. 3.37b). 
 
Figure 3.37 Characterisation of fusion SVs. (a) Incorporation analysis of the ΔN complex into 
preformed liposomes by detection of SNAP25 by western blotting. (b) Insertion and activity 
analysis of TF0F1 in ΔN complex/TF0F1 liposomes by acidification measurement in presence of 
the pH sensitive dye acridine orange.  
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Furthermore, the liposomes containing ΔN complex and TF0F1 fused with SVs 
(fig. 3.38). However, the estimated fraction of non-fused SVs, represented in 3.38b in 
the unboiled lane by monomeric synaptobrevin, is ~50%.  
 
 
Figure 3.38 Analysis of ΔN/TF0F1 liposome fusion with SVs. (a) Fusion of SVs and ΔN 
complex/TF0F1 liposomes containing lipids labelled with a FRET dye pair (NBD/Rhodamine) 
was monitored by dequenching of the NBD signal induced by lipid mixing. (b) Detection of the 
SDS resistant core complex formation after 20 min incubation at room temperature (ΔN:Sb ≈ 4:1 
(mol/mol)) as an indicator for SV and proteoliposome fusion. Monomeric Synaptobrevin in the 
non-boiled lane approximately represents the non-fused fraction of SVs compared to the overall 
Synaptobrevin (boiled lane). 
 
3.6.2 Cl- and Glutamate Dependend Acidification in Fused SVs 
The Cl- and glutamate dependent acidification in fused SVs was assessed. First, 
it was shown, that the V-ATPase inhibitor BafilomycinA1 efficiently impaired Cl- and 
glutamate dependend acidification in SVs (3.39b). Consequently, glutamate and Cl- 
dependent acidification in presence of BafilomycinA1 was monitored in fused SVs (fig. 
3.39c). Indeed, fused SVs exhibited Cl- and glutamate dependend acidification driven 
by TF0F1 alone. This clearly demonstrates, that the function of TF0F1 and VGLUT is 
preserved in fused SVs. However, the acidification was not pronounced which might be 
due to relatively high amounts of unfused SVs as can be concluded from the high 
abundance of monomeric synaptobrevin in figure 3.37b. Moreover, SV proteins might 
affect TF0F1 activity. Therefore, additional optimization of this approach has to be 
undertaken, including increasing the fraction of fused vesicles while simultaneously 
maintaining VGLUT1 and TF0F1 activity. Nevertheless, for the first time TF0F1 
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containing ΔN liposomes were generated and successfully fused with SVs by 
maintaining VGLUT activity solely driven by the external TF0F1. 
 
Figure 3.39 Acidification activity of fused SVs. (a) Acidification of SV lumen after addition of 
4 mM Cl-, 10 mM glutamate and 30 mM Cl-. Vesicular realkalinisation is promoted by blocking 
V-ATPase with BafilomycinA1 (0.5 µM). (b) Inhibition of V-ATPase with BafilomycinA1 blocks 
ΔµH+-dependent acidification. (c) Acidification of fusion SVs in the presence of 4 mM Cl-, 10 mM 
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The aim of this study was to clarify the stoichiometry of ionic coupling by which 
VGLUTs translocate glutamate. In particular, the role of Cl- and a putative K+/H+ 
exchange mechanism involved in the regulation of VGLUTs was investigated. These 
questions were addressed in a minimal system with recombinant mouse VGLUT1 and 
TF0F1 in artificial membranes, in SVs and a “hybrid” system of artificial liposomes 
fused with SVs. For the remainder of this chapter, results on VGLUT1 mechanism 
obtained using these tools will be discussed. 
4.1 Properties of VGLUT1/TF0F1 Liposomes 
4.1.1 Establishing an Electrogenic Proton Pump System 
The general framework to study VGLUT in a reconstituted system was to create 
a system that fulfills the energetic requirements of the secondary active transporter. 
Membrane potential (ΔΨ) and pH gradients (ΔpH) which are necessary for transport can 
be generated by artificial ion gradients [112] [74], but are not long-lived and generate 
only one component of the electrochemical gradient (ΔµH+) at a time. A system 
containing a proton pump generates ΔµH+ which is stable and contains both 
components. The proton pump has to be electrogenic, transporting protons only when 
charge balance is provided. A tight ionic coupling was not observed for E.coli F0F1 (fig. 
3.15) suggesting leakage through the liposomes. However, the His-tagged TF0F1 
exhibited ideal properties regarding activity and electrogeneity and was used as energy 
source in VGLUT1 liposomes (fig. 3.19).  
4.1.2 Expression and Purification of Differentially Tagged VGLUT1 
and its Activity 
For the investigation of VGLUT1 function in a reconstituted system active and 
pure VGLUT1 in sufficient quantities had to be obtained, which was a challenging task. 
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Thus, a considerable fraction of this work was invested in expression and particularly 
purification optimisation of VGLUT1. Physiological expression levels are too low, 
making heterologous expression inevitable. Several strategies for recombinant 
VGLUT1 expression and purification were followed. Cell free (CF) expression of 
VGLUT1 did not result in sufficient yields (fig. 3.9), whereas heterologous expression 
in insect cells yielded high quantities of transporter (fig. 3.10). Protein enrichment using 
His-tagged VGLUT1 was not successful (fig. 3.12), in contrast to previous reports [62] 
[74]. Two factors might have prevented sufficient enrichment of His6-tagged VGLUT1: 
1) The expression levels of VGLUT1 were not high enough to prevent binding of 
contaminants and 2) the micromolar affinity of the His6-tag to Ni
2+ was not sufficient to 
selectively bind VGLUT1. However, purification of VGLUT1 ultimately succeeded 
overcoming factor 2). VGLUT1 was tagged with the SBP-tag, which exhibits 
nanomolar affinity to streptavidin and therefore selectively binds the tagged protein. 
The tag enabled enrichment of VGLUT1 in the milligram range by a single affinity 
purification step (fig. 3.13).  
Another major obstacle apart from purification was the activity of VGLUT1 
derived from insect cells. When reconstituted with TF0F1 in liposomes it clearly 
exhibited glutamate translocation activity (fig. 3.22). Additionally, the size exclusion 
elution profile showed a sharp and uniform VGLUT1 peak indicating properly folded 
monodisperse protein (fig. 3.13). However, Cl- -dependent acidification was not 
observed in liposomes (fig. 3.26) and luminal chloride did not enhance glutamate 
uptake (fig. 3.27), in contrast to previous findings [21]. In light of the negative results 
regarding Cl- transport, mammalian cell expression was pursued in order to exclude a 
lack of activity in VGLUT1 derived from insect cells. Surprisingly, in terms of 
glutamate uptake mammalian cell VGLUT1 exhibited a slightly lower activity than 
insect cell VGLUT1 (fig. 3.28) and did not display any Cl- dependent acidification (data 
not shown). Glutamate uptake of 10 µg recombinant VGLUT1 from insect cells was 
comparable to the glutamate uptake from 20 µg of SVs, corresponding to ~3 µg 
VGLUT1+2 [7]. Consequently, VGLUT1 activity derived from insect cells can be 
estimated to be ~3fold lower than VGLUT activity from isolated SVs. However, Cl- 
dependent acidification in VGLUT1/TF0F1 liposomes was not observed even when the 
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amount of liposomes was increased suggesting that the lack of Cl- conductance in 
VGLUT1 does not originate from low VGLUT1 activity.  
4.2 Role of ΔpH and Cl- in the Regulation of VGLUT1 
4.2.1 VGLUT1 Does Not Exhibit Cl- Conductance 
The role of Cl- and the biphasic dependence of glutamate uptake on Cl- has been 
the focus of research for many years. On the one hand, it was suggested that low 
millimolar Cl- concentrations stimulate uptake by allosterically activating VGLUT1 
[71] [70] [74], and on the other, the stimulatory effect was assumed to originate from 
partial contribution of ΔpH to glutamate uptake [72] [21]. Although several studies have 
shown that glutamate transport primarily depends on ΔΨ [68] [124] [37] [38], the 
reduction of glutamate uptake by dissipating ΔpH implies that it is, at least partially, 
also dependent on ΔpH, suggestive of glutamate/H+ antiport by VGLUT [70]. However, 
loading of SVs by glutamate/H+ antiport would generate osmotic imbalance and induce 
SV swelling. Furthermore, when the effect of ΔpH is included in the bioenergetic 
calculations, the resulting driving force would concentrate glutamate ~1000 fold or 
more [125] [77]. The concentration of glutamate in the cytoplasm is ~10 mM [117] and 
the concentration in SVs is estimated to be 100 mM [126] [49], resulting in only a ~10 
fold increase. Hence, the role of ΔpH in glutamate uptake and in its biphasic 
dependence on Cl- remains unresolved. 
Clearly, Cl- induces acidification of SVs supposedly by providing counter charge for H+ 
[68]. However, whether a Cl- channel such as ClC3 or VGLUT1 mediates Cl- 
translocation is still under debate [70] [116] [21] [74]. A recent study showed a severe 
impairment in Cl- dependent acidification in SVs from VGLUT1 ko mice, indicating Cl- 
transport by VGLUT1. Furthermore, Cl- transport by VGLUT1 in liposomes 
reconstituted with VGLUT1 and a bacterial proton pump was observed [21]. On the 
other hand, Cl- transport by VGLUT2 incorporated in liposomes was not observed [74]. 
And strikingly, synaptic-like microvesicles (SLMVs) from astrocytes did not exhibit Cl- 
dependent acidification although expressing VGLUT2, which indicates that Cl- is not 
transported by VGLUT2 (unpublished data). Based on these conflicting reports on Cl- 
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conductance by VGLUTs, it was attempted to clarify whether VGLUT is involved in 
Cl- transport. The results obtained in this work with reconstituted VGLUT1 do not 
support Cl- conductance by VGLUT1, as Cl- dependent acidification in liposomes was 
not observed (fig. 3.26). Although activity of insect cell derived VGLUT1 was ~3fold 
lower than VGLUT activity from SVs (4.1.2) the lack of Cl- dependent acidification in 
VGLUT1/TF0F1 liposomes appears not to emerge from low VGLUT1 activity levels as 
increase of VGLUT1 amount did not affect the measurements. The observations in this 
work rather indicate that Cl- transport in SVs is mediated by another molecule than 
VGLUT1.  
4.2.2 Role of Luminal Cl- in the Regulation of Glutamate Uptake 
High luminal Cl- was early proposed to enhance glutamate uptake by exchanging 
luminal Cl- for cytosolic glutamate [75] [70]. During endocytosis, SVs are filled with 
~130 mM NaCl. Concentration gradient driven exchange of luminal Cl- for cytosolic 
glutamate would facilitate accumulation of glutamate preventing osmotic imbalance and 
SV swelling. Additionally, storage of the neurotransmitter as NaGlutamate would 
prevent luminal pH drop induced by storage as glutamic acid. Storage of glutamate as 
free acid would result in a luminal pH of ~3, which is two units lower than reported 
[127]. Unfortunately, the luminal content of SVs is difficult to manipulate and luminal 
ionic effects can only be addressed in a reconstituted system. Using such a reconstituted 
system containing VGLUT1 and a bacterial proton pump, a recent study indeed 
observed a stimulatory effect of high concentrations of luminal Cl- on glutamate uptake 
[21]. This finding supports a Cl-/glutamate exchange which is mediated by VGLUT1. 
By contrast, in this study an enhancing effect by high luminal Cl- on glutamate uptake 
was not observed (fig. 3.27). Essentially, this observation supports a lack of Cl- 
conductance by VGLUT1 but does not necessarily exclude the promoting effect of Cl- 
glutamate exchange, as Cl- conductance in SVs could be mediated by a Cl- channel. 
Particularly in this point the “hybrid” system of fused SVs (section 3.6) provides unique 
features, as it allows altering the SV lumen by simultaneously maintaining all native SV 
components. 
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4.3 Role of K+/H+ Exchange in the Regulation of VGLUT1 
4.3.1 Investigation of the K+/H+ Exchange Mode on SVs 
The exchange of a luminal H+ for a cytosolic monovalent cation can increase 
ΔΨ, therefore stimulate glutamate uptake [76]. Indeed, a Na+/K+-induced effect on 
glutamate uptake and ΔµH+ in SVs was observed, supporting the K+/H+ exchange 
mechanism. More precisely, addition of external K+ or Na+ diminished ΔpH (fig. 3.29) 
and preliminary measurements showed an increase in ΔΨ in the presence of Na+ (fig. 
3.35a). Furthermore, glutamate uptake was increased in the presence of K+ (fig. 3.31), 
which indicates a promoting effect on uptake by enhanced ΔΨ. However, EIPA, a 
blocker of Na+/H+ exchangers (NHEs), did not inhibit the K+ effect on glutamate uptake 
(fig. 3.31) and it did not suppress Na+/K+-induced realkalinisation of SVs (data not 
shown). These data suggest that NHEs might not be responsible for K+/H+ exchange. 
Based on these findings, the identification of the exchanger and the analysis of whether 
K+/H+ exchange is an intrinsic property of glutamatergic SVs were pursued. A putative 
candidate is VGLUT as it was reported to transport Na+ and Pi [47] and was suggested 
to implement glutamate/H+ antiport [70]. Exchange of K+ and H+ by VGLUT would 
make this mechanism specific to glutamatergic SVs. 
4.3.2 Indications for VGLUT1 Mediating K+/H+ Exchange 
In order to investigate VGLUT’s role in K+/H+ exchange, the K+ effect in dense 
core vesicles (DCVs) was inspected. Interestingly, DCVs, which express VMAT1, did 
not exhibit any K+/Na+-dependent realkalinisation (fig. 3.33). This finding strongly 
suggests that K+/H+ exchange is a specific characteristic of glutamatergic and/or 
gabaergic SVs. Bioenergetically this is plausible, as monoamine uptake is mainly driven 
by ΔpH, a ΔΨ enhancing mechanism which could even diminish uptake. By 
immunoisolating glutamatergic and gabaergic SVs it would be possible to explore 
whether the K+/Na+ effect is an exclusive property of glutamatergic SVs.  
The most striking finding supporting VGLUT’s role as a K+/H+ exchanger was 
the inhibition of K+ mediated effects on ΔµH+ by Evans Blue. K+ induced 
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realkalinisation in the presence Evans Blue was suppressed (fig. 3.34) as well as K+-
induced increase of ΔΨ (fig. 3.35). Although unspecific inhibition of SV functions by 
EB cannot be fully excluded, the maintenance of Cl--dependent acidification and 
Bafilomycin A1-induced realkalinisation (fig. 3.34) suggest that SVs were still 
functionally intact. Certainly, further evidence confirming this VGLUT mechanism is 
needed.  
The minimal reconstituted system established in this work is particularly suitable 
to address this question. Glutamate uptake stimulation in the presence of K+ in 
VGLUT1/TF0F1-reconstituted liposomes would support VGLUT1 as a K
+/H+ 
exchanger. Furthermore, VGLUT transfection of PC12 cells, rat adrenal medulla cells 
which contain aminergic chromaffin granules, and monitoring K+-mediated effects on 
ΔµH+ in these granules will give insight to VGLUT mediated K+/H+ exchange. 
4.4 Conclusion 
In this work, a reconstituted system containing recombinant mouse VGLUT1 
derived from insect cells and a tightly coupled proton pump was established. Using 
reconstituted VGLUT1/TF0F1 liposomes it was found that VGLUT1 does not function 
as Cl- shunt in contrast to previous reports [21] indicating that another molecule is 
transporting Cl- in SVs. However, studies on SVs exhibited a K+/H+ exchange 
mechanism which increases ΔΨ and therefore stimulates glutamate uptake which is 
supporting a recently published study [76]. Strikingly, the present work provides novel 
preliminary evidence that VGLUT functions as K+/H+ exchanger as inhibition of 
VGLUT1 suppressed K+ evoked pH increase in SVs. Furthermore, by fusing SVs with 
proteoliposomes containing the fusion core machinery and TF0F1 a unique system was 
established, that allows luminal manipulation of SVs. It was shown that SVs and TF0F1 
maintain their activity after fusion. By inhibiting the V-ATPase only fused SVs with 
changed luminal contents are addressed in measurements. Fused SVs are particularly 
suitable for analysis of the putative stimulating effect of high luminal Cl- on glutamate 
uptake. In figure 4.40 changes in VGLUT1 transport modes derived from the present 
study are depicted. 
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Figure 4.40 Proposed ionic coupling of glutamate transport. VGLUT1 is translocating 
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In neuronal signal transmission, vesicular neurotransmitter transporters play a 
key role in quantal size modification. They are filling synaptic vesicles (SVs) with 
neurotransmitter, fuelled by an electrochemical gradient (ΔµH+) across the membrane 
which is generated by the vacuolar ATPase (V-ATPase). Understanding the regulation 
of SV filling will resolve fundamental questions regarding synaptic function. In 
particular, questions addressing the vesicular glutamate transporter (VGLUT), which is 
filling SVs with the excitatory neurotransmitter L-glutamate, such as the mechanism 
and ionic coupling, remain unanswered. For instance, it is not fully understood which 
mechanism underlies the biphasic dependence of glutamate uptake on Cl-. Furthermore, 
there are inconsistent reports on a Cl- conductance by VGLUT1. Recently, a regulatory 
mode exchanging luminal H+ for cytosolic K+ which is affecting glutamate uptake by 
changing ΔµH+ has been proposed. 
In this study, particularly the transport of Cl- by VGLUT1 and a putative K+/H+ 
exchange mechanism involved in the regulation of VGLUT1 were investigated in order 
to unravel the ionic coupling of glutamate transport. These questions were addressed in 
a minimal system with recombinant mouse VGLUT1 and a proton pump from bacillus 
thermophilus (TF0F1) in artificial membranes, which was established in this work. In 
reconstituted liposomes containing VGLUT1 and TF0F1, VGLUT1 did not exhibit any 
Cl- conductance in contrast to previous reports. Additionally, high luminal Cl- 
concentrations did not enhance glutamate uptake, conflicting with recent studies. This 
finding further supported a lack of Cl- conductance in VGLUT1. By studying SVs, a 
K+/H+ exchange mechanism was observed supporting previous studies. Remarkably, 
preliminary observations in the present work suggest that VGLUT is mediating K+/H+ 
exchange in SVs. Furthermore, a “hybrid” system of SVs fused with proteoliposomes 
containing TF0F1 and a fusion mediating machinery was established. The unique benefit 
of “fused SVs” is that SV contents can be efficiently manipulated, which hitherto has 
been a challenging task. Preliminary measurements indicate that SVs and TF0F1 
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maintain their activity after fusion. Fused SVs provide a unique opportunity to study the 
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